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ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48 10 6 -1 34 6
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Thullbery, Matthew D., M.S., July 2006 Pharmaceutical Sciences
Genomic analysis of human neuroblastoma cells in response to paraoxon exposure 
Chairperson: Katie M. George, Ph.D.
Organophosphates (OP) belong to a diverse class of chemical compounds with 
applications for pesticide use as well as nerve gas agents. OPs are well-characterized 
neurotoxicants whose primary molecular target is acetylcholinesterase (AChE). By 
covalent modification of the enzymatic active site, OPs inhibit the hydrolytic function of 
AChE, resulting in acute toxic symptoms of hypercholinergic stimulation. We 
hypothesize that OPs are highly reactive compounds capable of interacting with other 
cellular proteins and eliciting additional, non-AChE-associated effects in neuronal cells. 
To begin to address this question, a human neuroblastoma cell line, SH-SY5Y, was 
exposed to 10 nM paraoxon (PX) for 3, 8, and 24 hours and changes in gene expression 
were analyzed using the Human Tox cDNA microarray chip. From the microarray data, 
a select group of genes, including ECMl and ODCl, that showed differential expression 
following PX exposure were analyzed by semi-quantitative polymerase chain reaction 
and immunoblot. Although microarry data was not confirmed with RT-PCR, ECMl 
showed increased protein expression following PX exposure. A comprehensive analysis 
of the microarray data using GoMiner software identified a number o f possible cellular 
processes targeted by PX. One of these processes, cellular proliferation, was further 
characterized and it was demonstrated that 10 nM PX significantly induces proliferation 
in SH-SY5Y cells.
n
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Chapter 1 
INTRODUCTION
The development of organic phosphorus (organophosphates, OP) compounds 
originated during the middle of the 19*'’ century with Jean Louis Lassaigne’s analysis of 
the reaction of alcohol with phosphoric acid. The possible use of OP’s as insecticides or 
nerve agents was realized in 1936 through the work of German chemist Gerhard Schrader 
(Rusyniak and Nanagas 2004). Schrader was in charge of developing new and improved 
insecticides when he created the compound Ethyl N,N-dimethylphosphoramidocyanidate 
(tabun) 1 (Figure 1.1), which became better known as nerve agent GA. Because of the 
time period, much of the continued effort in developing OPs was steered towards 
compounds that could be used as chemical warfare agents, although fully understanding 
the potential of OPs as insecticides. The potential of OPs to be used as chemical agents 
led to the German Ministry of Defense classifying Schrader’s OP compounds as 
confidential which initially prevented their development as commercial insecticides. 
Further work by Schrader resulted in the additional nerve agents 2-( fiuoro-methyl- 
phosphoryl)oxypropane (sarin, GB) 2 and 3-(fluoro-methyl-phosphoryl)oxy-2,2- 
dimethyl-butane (soman, GD) 3 (Talley 2001).
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Figure 1.1 Neurotoxic Organophosphorus Chemicals
1 : Tabun 2: Sarin 3: Soman
Many of these OP compounds have been stockpiled for years as neurotoxic agents 
or nerve gas for military use (Caglioti 1983). Despite an international ban on the use and 
production of these neurotoxic compounds, there is evidence that sarin 2 was used by 
Iraq during its conflict with Iran and during the first Gulf War (Black 1993). This has led 
to the suggestion that exposure to sarin 2 may be a contributing factor to the so-called 
Gulf War Syndrome (Ember 1996). Sarin 2 was also used by terrorists in an attack on a 
Tokyo subway in 1995 which resulted in twelve deaths and more than 5,000 casualties 
(Satoh and Hosokawa 2000).
While the early development of OP’s pursued differential nerve agents for 
military warfare, a new group of compounds came to the forefront for use as insecticides. 
In 1939 Paul Muller won the Nobel Prize for the creation of the organochlorine 
dichlorodiphenyltrichloroethane (DDT). Organochlorine compounds quickly became the 
most widely used pesticides around the world (Rusyniak and Nanagas 2004). The use of 
organochlorines as agricultural pesticides resulted in an effective pesticide with low 
human toxicity. With continued use however, the potential environmental impact of 
organochlorines led to their own demise after the realization DDT and its metabolites
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
bioaccumulate and biomagnify in the ecosystem and body tissue (Galloway and Handy
2003). By the 1970’s, the use of organochlorines as insecticides were either legally 
banned or heavily restricted, resulting in an increased use and production of OPs, and 
eventually OPs becoming the preferential insecticide used around the world.
OP compounds represent the largest group of chemical insecticides in use today 
with over half of the eight billion dollar (US dollars) insecticide world market being 
represented by OPs (Casida and Quistad 2004). OPs have been a critical part of 
increasing production of many crops including com, wheat, and cotton, as well as being 
an essential part of plant and lawn care in both the residential and commercial setting 
(EPA 1999). Additionally, certain OPs have been instrumental in the protection of public 
health against such mosquito-bome diseases as malaria, dengue fever, and encephalitis 
(EPA 1999). The demonstration by Schrader and coworkers that OP compounds exhibit 
insecticidal activity led to the first commercially developed OP, Bladen, in 1944 (Eto 
1974). Further development of OPs as insecticides led to the production of thousands of 
chemically different OP compounds. Currently, approximately 150 different OPs are in 
use accounting for roughly 60 million pounds of OPs being applied to roughly 60 million 
acres of agricultural land on a yearly basis. Another 17 million pounds of OPs are used 
non-agriculturally for the protection of human health and livestock (EPA 1999). The 
structures of some common OP insecticides are shown in Figure 1.2.
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Figure 1.2 Structure of some commonly used organophosphorous pesticides
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Organophosphorus compounds are neurotoxic agents whose main mechanism of 
action is the inhibition of serine hydrolases, the most critically of which is the widely 
distributed nervous system enzyme acetylcholinesterase (AChE; EC 3.1.1.7) (Fukuto 
1990; Carlson et al. 2000; Kardos and Sultatos 2000; Duysen et al. 2001; Ray and 
Richards 2001; Hong et al. 2003; Casida and Quistad 2004; Chambers and Oppenheimer 
2004; Kamanyire and Karalliedde 2004; Rusyniak and Nanagas 2004). The covalent 
modification of the active site serine by an OP causes the inhibition of AChE, blocking 
the hydrolytic function of the enzyme. The acute toxic symptoms of AChE inhibition are 
attributed to the over stimulation of acetylcholine (ACh) receptors (generally muscarinic; 
mAChr) in both the nervous system and effector organs (Ma et al. 2003).
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Cholinergic hyperstimulation following OP poisoning results in excessive 
glandular secretions and the well characterized clinical symptoms represented by the 
mnemonic word SLUDGE; Salivation, Lacrimation, Urination, Defecation, Gastric 
secretions, and Emesis (Rusyniak and Nanagas 2004). In addition to the acute symptoms 
of toxic OP insult, three other unique pathologies have been detailed, separate from the 
cholinergic effects of OPs. The “intermediate syndrome” typically originates one to three 
days after the resolution of the cholinergic effects, characterized by a muscular weakness 
which affects the limbs, respiratory muscles, and muscles of the neck. Recovery of 
muscle use generally happens five to eighteen days following the onset of symptoms 
(Rusyniak and Nanagas 2004). In response to certain OP’s, a second symptomology 
develops one to four weeks post-exposure, long after the cholinergic signs have subsided. 
This toxicity is known as organophosphate-induced delayed neuropathy (OPIDN) (Hong 
et al. 2003; Kamanyire and Karalliedde 2004; Costa 2006). Symptoms of OPIDN 
include a weakness of peripheral muscles in the hands and feet followed by a variable 
degree of sensory impairment. The third neurotoxic syndrome associated with OP 
exposure is a chronic neurological deficit that appears months to years after exposure.
This syndrome, termed organophosphate-induced chronic neurotoxicity (OPICN), 
exhibits signs of cognitive deficits in such areas as memory, concentration, and problem 
solving (Damodaran et al. 2006). OP exposure has also been linked to a number of non- 
cholinergic illnesses including cancer, pulmonary toxicity, Parkinson’s and vision loss 
(Imamura T 1988; Dementi 1994; Pogoda and Preston-Martin 1997; Senanayake 1998; 
Bhatt MH 1999; Meinert et al. 2000; Lotti and Moretto 2005).
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While the clinical symptoms of OP toxicity appear to be well-understood, the 
cellular and molecular mechanisms of the toxicities that each OP compound propagates 
are far from figured out. The naïve hypothesis that all OP toxicity is caused by a similar 
mechanism, the inhibition of AChE, is carefully being replaced with a hypothesis that OP 
compounds interact with a multitude of specific molecular targets and cellular pathways 
that contribute to a wide variety of clinical symptoms (Costa 2006). Elucidation of the 
principal biochemical mechanisms and cellular pathways (cholinergic and non- 
cholinergic) induced by OP exposure could result in improved assessment of health risks 
associated with OP exposure.
A detailed discussion of OP exposure is needed to further define the limited 
knowledge of the mechanisms of OP toxicity. The following chapter of the thesis is 
divided into three parts; 1) A detailed description of organophosphates, 2) The 
mechanism of AChE, NTE, and serine hydrolase inhibition following OP insult, and 
finally, 3) a review of research involved in delineating the secondary targets (non-serine 
hydrolases) of OPs.
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Chapter 2 
BACKGROUND
The wide spread use of organophosphates as insecticides plays a critical role in 
the production of the world’s crops. It has been estimated that nearly half of all produced 
crops in the world would be lost to the devastating effects of insects and other pests if 
pesticides were not applied. Even with widespread use of pesticides within the United 
States, one-tenth of the crops are destroyed each year resulting in a $20 billion dollar loss 
(Talley 2001). OPs also play an important role as insecticides in the non-agricultural 
setting as well. OPs are used on lawns, gardens, flowers and even pets. Despite the 
recognized fact that organophosphates are neurotoxic agents, the importance of them as 
insecticides leads to their continued production and use. An understanding of OP 
chemical structure and different chemical characteristics is an important first step in the 
process of gaining an insight into OP action on biological systems.
Organophosphate structure and activity
The simplest representation of an OP is a phosphorus (P) atom that is 
tetracoordinate and pentavalent (Mileson et al. 1998). Three of the groups attached to the 
P are bound by a single bond while the fourth substituent is attached by a double bond. 
This general structure can be represented by Figure 2.1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure 2.1 General structure of an organophosphate
Ri
(S) 
p  X
R2
RI and R2 are generally alkoxy groups (R1,R2 = O-Methyl or O-Ethyl), while X 
is the most sensitive to hydrolysis during phosphorylation, and as such, has been termed 
the “leaving group”. Most OP insecticides are phosphorothionates, compounds that 
contain a P=S (sulfur) bond. For phosphorothionates to become active, the P=S must 
first be converted to an oxon (P=0), resulting in the highly reactive phosphate OP (four 
oxygen groups bound to the phosphorous). Other subclasses of OPs include 
phosphorodithioates which are similar to phosphorothionates but with the leaving group 
oxygen replaced with a sulphur. A phosphate with two R group oxygens, a sulfur and a 
leaving group nitrogen (N) are phosphoramidates.
Although OPs share a common mode of action, the inhibition of AChE, they are a 
chemically diverse group of compounds that also exhibit a variable toxic effect. The 
chemical reactivity of OPs is dependent on the chemical structures and different 
substituents attached to the phosphorus. The electrophilicity of the phosphorus is the 
determining factor in reactivity and is generally determined by the chemical makeup of 
the leaving group, X. Structure activity relationships between different OPs have shown 
a direct link between the anticholinesterase activity and the reactivity of the phosphorus
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
molecule (Fukuto 1990). The more electron-withdrawing groups on the leaving group 
that are attached to the phosphorus, the more reactive the compound becomes, while 
electron-donating groups on X diminish the activity o f the OP. Electron withdrawing 
groups remove electrons from the phosphorus and make the P-X bond more susceptible 
to nucleophilic attack by the hydroxyl group of the serine during phosphorylation. The 
steric properties of the alkyl chains also influence the OP’s ability to phosphorylate. 
Increased chain length and or increased branching of the R1 and R2 groups markedly 
decreases reactivity o f the OP (Fukuto 1990).
Conversion of thionates to oxons
While high chemical reactivity (i.e. phosphorylation of serine hydroxyl moiety) of 
an OP is dependant on the P=0 bond, most insecticides contain the P=S linkage. The 
P=S bond is a relatively stable bond and is not as polarized as the P=0 due to the lower 
electronegativity of the sulphur group. The potent insecticidal activity o f OPs with the 
P=S bond is due to the metabolic activation of the P=S into P=0 by metabolic oxidation 
(Dauterman 1971). The metabolic transformations of OP’s have been the subject of 
extensive research. Fifteen years ago it was believed this reaction was mediated by the 
mixed function oxidases (MFO), a ubiquitous enzyme system responsible for the 
oxidation o f xenobiotics in animals (Fukuto 1990). Further research more carefully 
defined the roles of these MFOs, the cytochrome P450 family of enzymes (CYPs). 
Although there are many gaps in the knowledge of the exact CYP involved in the 
reaction with each unique OP, the available data point toward a complex picture. The 
CYPs involved in the oxidative désulfuration of P=S to P=0 show unique substrate 
specificities. The insecticide parathion is bioactivated to the oxon, paraoxon (PX) by the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
10
CYP3A4/5 and CYP2C8 while diazinon is activated by CYP2C19 (Kappers et al. 2001; 
Mutch et al. 2003). Certain CYPs have also been shown to be involved in different 
transformations (non-activation reactions) o f OPs such as, oxidative dearylation, 
oxidative dééthylation, and the reduction o f nitro groups on OP side chains (Costa 2006). 
CYPs also play an important role in the metabolic deactivation of OP’s once they become 
oxons.
Chemical breakdown of OPs
The degradation of OPs occurs in both biological systems as well as in the 
environment. OPs as a class are a chemically reactive and rather unstable class o f 
compounds. All OPs are tertiary esters which make them susceptible to hydrolytic 
degradation. Cleavage o f any of the bonds can occur by both chemical and enzymatic 
cleavage which results in detoxification products (Fukuto 1990). OPs in the environment 
are readily hydrolyzed in soil, sediment, or surface water (Walker 2001). Relatively 
quick hydrolytic cleavage of OPs within the environment into non-toxic products is one 
o f the main reasons OPs gained favor as insecticides over the more chemically stable 
organochlorines, which tend to bioaccumulate. Once a thionate (insecticide) becomes an 
oxon, biological degradation occurs via one or more of the following pathways, 
cytochrome P450 deactivation, catalytic hydrolysis, and/or non-catalytic hydrolysis.
The CYP family plays an instrumental role in the enzymatic degradation of OPs 
within a biological system. CYPs, which have been shown to be involved in the 
metabolic activation o f OPs, have also been implicated in the deactivation. CYP2B6 has 
been shown to oxidize chlorpyrifos while also degrading parathion into the non-toxic 
products p-nitrophenol and diethylphosphorothioic acid (Hodgson 2003). Catalytic
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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hydrolysis of oxon OPs happens by way o f a number of enzymes known as the 
phosphotriesterases, or A-esterases. Early studies by Aldridge discovered a group o f 
enzymes that hydrolyze aromatic compounds and certain OPs such as paraoxon (Aldridge 
1953). These enzymes were named A-esterases and could not be inhibited by OPs. 
Further research into the A-esterases and their detoxification of OPs resulted in the 
characterization o f the A-esterase paraoxonase. Studies have shown that purified 
paraoxonase injected into animals increases their resistance to the toxic effects of OPs 
(Main 1956; Costa et al. 1990). A second group o f esterases were also discovered that 
were important in the detoxification o f OPs. However, compared to the A-esterases, 
these serine esterases were shown to be inhibited by OPs and were named the B- 
esterases. The B-esterases are unable to hydrolyze OPs, but by becoming inhibited and 
covalently bound to the OP, remove the OP from the plasma. Identified B-esterases 
include carboxylesterases, butyrylcholinesterase (BuChE), and the widely researched 
acetylcholinesterase (AChE). After the discovery that AChE is the primary target of OPs 
within a biological system, the focus of OP research was placed squarely on the 
mechanism and consequences of this interaction. The next section will focus on the 
mechanism o f inhibition of AChE by OPs, as well as the inhibition of other major serine 
hydrolases.
OP inhibition of AChE
Acetylcholine (ACh) is one of the major neurotransmitters in the peripheral and 
central nervous system. While many other neurotransmitters are removed from the 
synaptic cleft by re-uptake into the cell, the majority o f ACh is hydrolyzed into the 
inactive products choline and acetic acid by the enzyme AChE (Rotundo 1983; Massoulie
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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et al. 1993; Massoulie et al. 1998; Rotundo et al. 1998). AChE is one of the fastest 
enzymes known with an extremely high catalytic efficiency and turnover rate exceeding 
IxlOM molecules of ACh per second (Quinn 1987; Jennings et al. 2003). The active site 
serine located within the gorge of AChE is the main player o f the hydrolysis reaction and 
is responsible for the enzymatic cleavage of ACh. AChE has been studied extensively 
for many different reasons for almost a century now. Areas of AChE research include as 
an enzyme, a therapeutic venue, a marker of cholinergic neurons, cell to cell interactions 
and as a target of pesticides and nerve agents, namely organophosphates (Rotundo 2003). 
Research into AChE and OPs concluded that this same active site serine is also the target 
o f organophosphates.
The mechanism o f phosphorylation of the active site o f AChE can be divided into 
three parts. The first action is the phosphorylation ( 1 ), followed by one of two exclusive 
steps, either reactivation ( 2 ) (dephosphorylation), or a chemical reaction termed “aging”
( 3 ), illustrated in figure 2.2.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure 2.2 Inhibition of AChE by organophosphates
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Organophosphates are substrates of AChE and their hydrolysis results in the 
phosphorylation of the active serine, effectively blocking the action of the enzyme on its 
physiological substrate, ACh (1). The resulting chemical bond between the phosphorus 
and active site hydroxyl group is much more stable than the bond between the carbonyl 
carbon o f ACh and active site. Depending on the structure of the OP, the 
phosphorylation can last from a few h to several days (Gallo MA 1991). Following 
phosphorylation, the phosphorus-enzyme bond can be hydrolyzed by water or an oxime 
(2). While water is a weak nucleophilic agent, highly nucleophilic oximes such as 2- 
PAM (pralidoxime) can readily facilitate the reactivation of phosphorylated AChE 
(Chambers and Oppenheimer 2004). An alternative fate results when the phosphorus 
group attached to the active site is dealkylated, resulting in the loss of one of the alkyl
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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groups (RI or R2), the enzyme-OP complex becomes “aged” (3). Aging results in an 
OP-AChE conjugate that contains a phosphate oxyanion that is unable to regain enzymic 
activity. Dealkylation (aging) strengthens the phosphorus-enzyme bond and AChE is 
irreversibly inhibited (Mileson et al. 1998).
Non-AChE esterase targets of OPs
Analogous to the inhibition of AChE by OPs, other serine hydrolases can be 
inhibited by OPs including butyrylcholinesterase (BuChE), carboxylesterases (CE), and 
neuropathy target esterase (NTE), the enzyme implicated in organophosphate-induced 
delayed neuropathy (OPIDN). The essential feature of the serine hydrolases is the 
nucleophilic serine that attacks the OP (O'Neill 1981). The inhibition and subsequent 
dephosphorylation (or aging) o f these serine hydrolases depends on the nucleophilicity, 
lipophilicity, and stereospecificity of the OP and the positioning and nature of the active 
site serine (Casida and Quistad 2004).
It was originally thought that both BuChE and the carboxylesterases (CE) did not 
serve an important physiological function in the body except as xenobiotic metabolizing 
enzymes, and that their elimination had little if  any negative impacts on physiology or 
health (Chambers and Oppenheimer 2004). These enzymes were thought to act as 
prophylactics in the protection o f the “important” enzyme AChE by becoming inhibited 
and subsequently destroying the OP compound by blocking the OP from further 
phosphorylation. Certain CEs have been shown to be more sensitive to OPs than AChE 
which would support the idea of CEs acting as prophylactics (Ray and Richards 2001). 
Not surprisingly, further research into the roles o f BuChE and CE attributed important, 
specific functions to these enzymes outside o f their role as prophylactics. The enzyme
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
15
BuChE has been shown to be important in the hydrolysis of choline and non-choline 
esters including the neurotransmitter ACh. BuChE also enhances the activity of certain 
proteases including trypsin and has been implicated in cellular proliferation and neurite 
outgrowth during neuronal development (Darvesh et al. 2003). CEs are ubiquitous 
enzymes that cleave carboxylic esters into their corresponding carboxylic acids and 
alcohols. Mammals have over 300 different CEs that have different specificities for a 
variety of substrates. CEs were originally believed to be important in only drug and 
xenobiotic metabolism but have recently been recognized for their role in the processing 
o f endobiotic compounds (Redinbo and Potter 2005). This includes functioning in 
cholesterol homeostasis and fatty acid metabolism. With new roles being discovered for 
serine hydrolases that are important to the physiology of the cell, research into the 
inhibition of these hydrolases following OP exposure becomes more critical. When these 
hydrolases become inhibited, there is a possibility that other cellular pathways and up- or 
downstream targets are affected.
Following exposure to OPs, there is a clear toxicological description of the acute 
cholinergic crisis that occurs after with the inhibition of AChE. The clinical symptoms of 
OPIDN have also been fairly well documented that occur well after the cholinergic crisis. 
Research into the mechanism of OPIDN postulated that the inhibition (and subsequent 
aging) of a novel enzyme, neuropathy target esterase (NTE) by certain OPs is the cause 
of OPIDN (Barrett et al. 1985). Yet, while NTE has been implicated as the initiator of 
OPIDN following its inhibition, the physiological role of NTE and its involvement in the 
manifestation of OPIDN have yet to be fully characterized. NTE has been shown to have 
a physiological role in lipid metabolism and homeostasis (Zaccheo et al. 2004). The
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phosphorylation and aging of NTE happens within hours of exposure, yet the clinical 
symptoms of OPIDN manifest 2-4 weeks afterwards. The clinical symptoms attributed to 
OPIDN begin with a tingling and loss o f sensation in the hands and feet. Cramping pains 
in the legs ensue, followed by rapidly progressive muscle weakness of the lower limbs. 
Severe cases include loss of the ability to coordinate muscle movements and eventual 
paralysis of lower and upper extremities. Patients may eventually regain function of 
limbs with diminished operation (Rusyniak and Nanagas 2004). Pathological studies 
after NTE inhibition but before clinical symptoms, demonstrated degeneration of axons 
and their terminals as well as spinal cord atrophy. The deterioration of the peripheral 
axons is directly proportional to the length of the specific axon (Rusyniak and Nanagas
2004). Interestingly, the symptoms o f OPIDN appear with only a select group of OP’s. 
OPIDN symptoms are also unrelated to the cholinergic and intermediate symptoms, occur 
well after those symptoms have subsided, and cannot be attributed to the inhibition of 
AChE, which occurs with every type o f OP compound (Costa 2006). With the growing 
body of research on NTE and OPIDN, the mechanism and pathways from the progression 
of NTE inhibition to axonal degradation to clinical symptoms of OPIDN remain 
undefined.
Additional non-ACh£, non-NTE syndromes
The clinical symptoms of the “intermediate syndrome” following OP exposure, 
which are characterized by a weakness of respiratory, neck and proximal limb muscles, 
have not been directly correlated with a molecular target. The signs appear after 
cholinergic resolution but before OPIDN, yet the only hypothesis concerning the effects 
o f the intermediate syndrome is cholinergic receptor desensitization due to prolonged
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cholinergic stimulation (Lotti 2001). Again, the exact mechanism of the syndrome is 
unclear.
To further confound the research o f mechanisms of symptoms associated with OP 
exposure, is the somewhat controversial research studying the pathology o f the chronic 
neurological conditions persisting long after the OP insult. Studies have shown different 
cognitive effects following OP exposure including deficits in memory, problem solving, 
and concentration (Rusyniak and Nanagas 2004). There have also been reports of 
psychiatric problems such as depression and anxiety. However, not all groups studying 
cognitive effects following OP exposure have shown the same associations. With this 
multitude of research describing different clinical syndromes associated with OP 
poisoning, and the firm belief that these symptoms cannot be adequately explained solely 
by the inhibition o f AChE or NTE, scientific studies began to investigate secondary 
targets and pathways affected by OP compounds.
Secondary targets of OP exposure
It is difficult to make generalized comments about the mechanistic action of OPs 
on biological systems outside the inhibition of AChE. Many studies have been done on 
different model systems with a wide array of different OPs at all types of concentrations 
resulting in a multitude of responses. Because there are many different OPs and 
concentrations used in OP research, it is important to not make a broad generalization 
about all OPs when discussing secondary targets. However, there is a significant quantity 
of research that points to the fact that OPs do affect secondary targets and pathways 
within the cell. The next section will discuss four different broad groups of targets 
presented here as secondary targets of OPs. The first section will be unique DNA /
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mRNA / protein products that are modulated, altered, or blocked by OPs. The next 
section will look at certain well established pathways in the cell affected by OPs. The 
affect o f OPs on both the immune system and cognitive behavior will make up the last 
two parts o f the discussion.
DNA: Certain OP methyl esters have been shown to damage DNA through 
méthylation. This alkylation of DNA can cause point mutations within the DNA strand, 
opening the strand to possibilities o f mismatched pairs. The OP trichlorfon was 
demonstrated to inhibit the enzyme O^-methylguanine-DNA methlytransferase which is 
involved in the catalytic repair of O^-methy 1 guanine (Badawi 1998). Inhibition of this 
enzyme further complicates the effect o f DNA alkylation.
Gene expression changes: Cholinergic gene expression changes are generally an 
indirect effect resulting from increased levels of ACh following AChE inhibition by OPs. 
Expression levels of AChE mRNA was monitored at different time-points following the 
injection of the nerve agent Sarin (0.5x LD5 0) into rats (Damodaran et al. 2003). AChE 
showed differential expression in different regions of the brain following sarin treatment 
in comparison to control. Two hours following treatment, AChE was induced almost 
three-fold with a return to basal level by 24h.
Mouse brain slices exposed to diisopropylfluorophosphate (DFP) showed 
overexpression of c-fos (early response transcription factor), choline acetyl transferase 
(ChAT), and vesicular ACh transporter (VAChT) (Kaufer et al. 1999).
OPs are able to directly inhibit steroid hormone levels by blocking 
adrenocorticotropin and cAMP-stimulated steroidogenesis (Civen et al. 1977). More 
recent investigations indicate OPs may block steroidogenesis by blocking transcription of
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the steroidogenic acute regulatory (StAR) gene (Walsh et al. 2000). The StAR protein 
mediates the rate-limiting step in steroidogenesis and its decreased expression can lead to 
impaired reproductive function.
Protein modulation: The response of cholinergic receptors, both muscarinic 
(mAChR) and nicotinic (nAChR), has also been studied in response to OPs. Because of 
the different model systems (jn vitro and in vivo) and different types and concentrations 
of OPs used, it is difficult to make a generalized summary about the effects o f OPs on 
cholinergic receptors. Nevertheless, OPs directly modify cholinergic receptor activity 
(activating and blocking), downregulate receptor number (both directly and indirectly 
through the inhibition of AChE), and cause differential regulation o f both nAChR and 
mAChRs mRNA (directly and indirectly) (Jett et al. 1993; Khan et al. 2000; Casida and 
Quistad 2004).
The phosphorylation (activation) of Ca^VcAMP response element binding protein 
(CREE) was shown to occur following low dose exposure (doses that do not inhibit 
AChE) of primary cortical neurons with chlorpyiifbs (Schuh et al. 2002). CREE is an 
important activator of gene transcription and is involved in the control of many cell 
processes, including hormone synthesis in endocrine cells and the formation of long-term 
memory in neurons (Alberts 2002).
The nerve agent Soman was shown to directly inhibit the release of 
norepinephrine from rat brain cortical slices and was suggested that it was acting through 
direct action at NMDA receptors (Tang and Cassel 1998).
High non-lethal doses of malathion induced variable amounts of cell roimding and 
shrinkage as well as progressive loss of cell-cell and cell-substrate adhesion in cultured
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breast cancer cells (Cabello et al. 2003). This toxicological phenotype was found to be 
due to the decreased expression o f two different epithelial adhesion proteins, E-cadherin 
and B-catenin. At lower concentrations o f malathion, increased expression o f two small 
GTPases (Rho and R a d )  were measured.
Cellular pathways: OPs have been demonstrated to alter cellular pathways. 
Calcium (Ca^^ is involved in many different aspects o f the cell including functioning as 
a ubiquitous intracellular messenger and integral part of neurotransmission. Ca^^ 
homeostasis within the cell is an important part of signaling pathways in the cell and is 
directly modified by OPs. Sun et al. showed low levels of PX (0.1 nM-10 nM) exposure 
significantly increased basal levels of Ca^^ in human parotid salivary cells (HSY) (Sun et 
al. 2000). Pre-exposure of the HSY cells to nanomolar levels o f PX also increased Ca^^ 
release from 1,4,5-inositol-triphosphate (Ip3 )-sensitive stores following addition of a 
muscarinic agonist, suggesting PX increases the sensitivity o f IP3 receptors (Sun et al. 
2000). It was hypothesized that PX is acting directly on these downstream targets o f the 
phosphoinositide signaling pathway.
High concentrations (mM) of PX have been shown to cause a transient increase in 
intracellular Ca^^ in SK-N-SH-SY5Y cells (Hong et al. 2003). However, this same 
increase was shown with the hydrolysis products of PX as well. Yet, repeated doses of 
50 pM PX decreased the basal level of intracellular calcium over time (Hong et al. 2003). 
Clearly PX affects different mechanisms involved in calcium signaling pathways and the 
homeostasis of intracellular calcium.
PX has also been demonstrated to induce apoptosis. A mouse T-lymphocytic 
leukemia cell line EL4 was exposed to 10 nM PX for 16 h. Employing a combination of
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specific caspase inhibitors, it was shown that PX induced apoptosis by disruption o f the 
mitochondrial transmembrane potential, which in turn caused the release o f cytochrome c 
into the cytosol and subsequent activation of caspase-9 (Saleh et al. 2003). Caspase-9 
then cleaved the effector caspase-3 which began the downstream events of apoptosis.
OPs have also been implicated in producing reactive oxygen species (ROS) which 
induces oxidative stress and a cellular response. ROS are either free radicals, reactive 
anions containing oxygen atoms, or molecules containing oxygen atoms that can produce 
free radicals or are chemically activated by them. The main damage to cells results from 
the ROS-induced alteration o f macromolecules such as polyunsaturated fatty acids in 
membrane lipids, essential proteins, and DNA. Lipid peroxidation has been suggested as 
the molecular mechanism involved in OP oxidative stress (Khrer 1993). When oxidative 
stress occurs, a large number of different ROS scavenging enzymes are released to 
remove the oxidative free radicals. Clinical studies of malathion-exposed patients 
detected increased levels o f free radical scavenging enzymes superoxide dismutase, 
catalase, glutathione peroxidase, glutathione-S-transferase and gamma glutamyl 
transpeptidase enzymes in blood samples in comparison to control (Banerjee et al. 1999; 
Seth et al. 2001). OP induced lipid peroxidation has also been demonstrated in rat brains 
and human erythrocytes (Gultekin 2000; Verma 2001).
Immune responses: The elimination and/or inactivation of foreign bodies in a 
biological system are performed by the immune system. The immune system is 
composed of adaptive (have memory) and innate (no memory) elements (Alberts 2002). 
Innate immune responses are not specific to a particular pathogen and rely on proteins 
and phagocytic cells to recognize conserved features o f pathogens and become quickly
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activated to help destroy invaders. The adaptive immune response is a more specialized 
response that has the ability to recognize and remember foreign pathogens and synthesize 
antibody molecules that react specifically to destroy or inactivate the stimulating 
pathogen (antigen). There is a large body o f evidence that illustrates the capability o f 
OPs to cause immunotoxicity, which is defined as an adverse effect on the immune 
system or its component parts. Research using animal models has demonstrated two 
general characteristics of the immune response after OP exposure. Acute doses to 
animals that cause cholinergic toxicity show decreased immune function within the 
animal. Low doses of OPs that do not inhibit AChE, produce enhanced immune function 
(Pruett 1992). While it is generally difficult to identify the exact molecular targets and 
mechanisms o f OP immunotoxicity, it is most likely a combination o f immune system 
targets that elicits the immunotoxic effect. Serine hydrolases are involved in the 
thrombin systems of the immune system and different esterases are associated with the 
cellular membranes o f immune system lymphocytes and monocytes (Stepanovic 1998). 
The inhibition of these serine hydrolases and esterases could potentiate the effects o f OP- 
induced immunotoxicity (Galloway and Handy 2003). OPs could also possibly cause 
oxidative stress to lymphoid tissues or different immune organs. Indirect effects on the 
immime system could be propagated by altered cholinergic output to different lymphoid 
organs as well as a chronic OP toxicity causing changed metabolism followed by 
malnutrition and subsequent immunodépression (Galloway and Handy 2003).
The cytokine IL-1P is one of several cytokines involved in inflammation and the 
immune response. Elevated levels of IL-ip are associated with both injury and illness. 
Rats injected with soman (1 x  LD50), showed increased IL-lp mRNA and protein levels
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30 min and 6 h, respectively, post-exposure (Svensson et al. 2001). The highly reactive 
nature o f OPs is able to induce a multitude of different effects within an organism to 
cause immunotoxicity.
Cognitive defects: Long-term cognitive deficits have also been shown to be 
associated with OP exposure. The cessation o f cholinergic toxicity following OP insult 
can be followed by a so called “intermediate syndrome”, OPIDN, or the possibility of 
some type of neurological cognitive deficit. This third type of neurotoxic action of OPs 
has just recently been named organophosphate-induced chronic neurotoxicity (OPICN) 
(Damodaran et al. 2006). OPICN symptoms have been characterized in response to large 
and sub-clinical doses o f OPs. Specific examples of OPICN have occurred in victims of 
the sarin attacks on the subways of Tokyo and in veterans o f the first Gulf War who were 
suspected o f low level exposure to sarin (Damodaran et al. 2006). While no specific 
targets have been linked, there are many clinical cases of victims of OP exposure that 
show a definite cognitive defect. The results from several studies have demonstrated the 
presence of OP-induced learning impairments, loss of concentration, depression, and 
difficulty in forming memories (Prendergast et al. 1998; Stone et al. 2000; Rusyniak and 
Nanagas 2004). The pathology of these cognitive deficits has yet to be clearly 
demonstrated; current theories include the down regulation of either cholinergic and non- 
cholinergic receptors (cholinergic receptors involved in memory formation), neuronal cell 
death, or some other unidentified brain proteins affected by OPs (Rusyniak and Nanagas 
2004).
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Summary
The reaction o f OPs with AChE and the cholinergic toxicity that follows is fairly 
well characterized. In general the neurotoxicity post OP insult is attributed to the 
inhibition of AChE. However, three other developed clinical syndromes have been 
attributed to OP exposure and cannot solely be explained by AChE inhibition. The so 
called “intermediate syndrome”, organophosphate-induced delayed neuropathy (OPIDN), 
and the neurotoxic cognitive deficit OPICN have been the subject of different studies, yet 
the precise mechanism and pathways affected that bring about the clinical symptoms are 
still unclear. The characterization o f the mechanism of OPs phosphorylating the active 
site serine o f AChE, brought about the realization that OPs might also be targeting 
secondary biomolecules in the cell including other serine hydrolases and esterases, as 
well as yet unidentified protein and/or pathways. Further investigations into secondary 
targets of OPs uncovered a number of different non-AChE targets within the cell, 
including cholinergic receptors and other specific protein products (as described above). 
However, the discovery o f these secondary targets did little to further the understanding 
of non-cholinergic toxicity following OP insult. A clearer understanding of cellular 
pathways affected by OPs and the different mechanisms by which OPs cause toxicity is 
needed.
The wide use of OPs as insecticides in both the agricultural and urban setting will 
continue for the foreseeable future (Costa 2006). OPs are relatively inexpensive and have 
low bioaccumulation within the ecosystem. However, because OPs are not selective, 
human exposure is of concern and research into the targets and mechanisms of OP
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toxicity outside of cholinergic hyperstimulation is desirable. The work introduced in this 
study begins to address these current issues in organophosphate toxicology. Initially, an 
analysis o f gene expression changes in response to an acute, low-dose of the 
organophosphate paraoxon was performed using cDNA microarray and SH-SY5Y human 
neuroblastoma cells. The next phase of research involved confirming gene expression 
changes using more traditional techniques such as RT-PCR and immunoblot. Following 
confirmation o f genes, gene data from the microarray experiments were organized into 
groups designated by a set of genes involved in specific cellular pathways. Additional 
experiments were devised to test the modulation of these pathways by paraoxon.
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Chapter 3 
OBJECTIVES / SPECIFIC AIMS
1. Identify and compare reproducible changes in gene expression following an acute, 
low dose, organophosphate (paraoxon (PX), vehicle) exposure to a human 
neuroblastoma cell line, identified by cDNA microarray with an in-house human 
tox cDNA chip.
2. Confirm a select gene expression (genes involved in a certain cellular pathway 
such as apoptosis or proliferation) change from Aim 1 by semi-quantitative 
reverse transcription polymerase chain reaction (RT-PCR), protein analysis, 
and/or enzyme activity assay.
3. Experimentally test the hypothesis that a specific cellular pathway (identified 
from microarray data in Aim 1) has been affected by exposure to PX.
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Chapter 4 
METHODS AND MATERIALS
Cell Culture:
SH-SY5Y human neuroblastoma cells (ATCC) were maintained in DMEM/F-12 
(Dulbecco’s Medium: Ham’s F-12, 1:1 mix) medium supplemented with 10% (v/v) fetal 
bovine serum (FBS), 60mg/l (100 U/ml) penicillin and 100 mg/1 streptomycin, in a 
Forma Scientific Incubator at 37° C in a humidified atmosphere of 95% air, 5% CO2 .
Cells were grown in monolayer culture and harvested at confluence for further passage 
by standard cell culture techniques. Cells were harvested using 0.05% trypsin/0.53 mM 
EDTA in HBSS.
Paraoxon (PX) Treatment:
Treatment was performed on SH-SY5Y cells in passages 4-8. Paraoxon (98.6% 
purity) was purchased from ChemService (West Chester, PA) and was diluted to working 
concentrations in acetone. Cells were treated with either 10 nM PX or acetone (0.1%) 
alone as a vehicle control.
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Microarray Analysis;
RNA purification: SH-SY5Y cells were passed into T-75 flasks at a density of 
1x1 o’ cells/flask and allowed to incubate 48 h prior to treatment. Cells were exposed to 
10 nM PX or acetone control and RNA was harvested at three specific time-points- 3, 8, 
and 24 h. Each PX-treated flask had a corresponding control flask treated with acetone 
for the exact same time. Cells were harvested by scraping and RNA extracted and 
purified with the RNeasy Mini Kit (Qiagen, Valencia, CA). Following purification of the 
RNA, spectrophotometer measurements (NanoDrop ND-1000, NanoDrop Technologies, 
Wilmington, DE) were made and only RNA with a 260/280 ratio of 1.9-2.1 was used in 
the microarray analysis.
Conversion o f RNA to fluorescentlv labeled cDNA: Conversion of the RNA to 
fluorescently labeled cDNA was carried out using the Superscript Plus Direct cDNA 
Labeling System (Invitrogen, Carlsbad, CA). Briefly, 10 pg of RNA was incubated with 
5 pg of Oligo(dX) 2 0  primer at 70®C for 10 min and then placed on ice. Following 
incubation, the RNA-Oligo mix was added to First-Strand buffer (final concentration= 50 
mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCW, 0.01 M DTT, Nucleotide Mix 
(mixture of dCTP, dGTP, dATP, dTTP, and labeled dUTP in 10 mM Tris (pH 8.0), 1 mM 
EDTA), 40 U of RNaseOUT, and 800 U of Superscript III RT. PX-treated RNA was 
incubated with Alexa Fluor 647-aha-dUTP Nucleotide Mix while the control RNA was 
incubated with Alexa Fluor 555-aha-dUTP Nucleotide Mix, for three h at 46°C. The
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labeled cDNA was then purified and checked for labeling efficiency using the Nanodrop 
spectrophotometer.
Hybridization: Analysis was performed for each time-point in duplicate using an in- 
house Human Toxicology cDNA Microarray Chip (version 3, Dr. Mark Pershouse Lab, 
University o f Montana, Missoula, MT) that contained approximately 1600 unique 
cDNA’s (each slide printed with 6 replicate spots of each gene) of genes generally 
implicated in a toxic insult. Labeled probes were denatured for 2 min at 95°C, snap 
cooled on ice, and then added to the Human Tox microarray chip and allowed to 
hybridize overnight at either 42**C or 50°C. The hybridized slides were quickly agitated 
in IX SSC, 0.01% SDS, followed by a) 2X two min washes in IX SSC, and b) 2X two 
min washes in 10 mM TE. Washed slides were quickly dried by centrifugation and 
stored in a dark box until they were ready to be scanned.
Scanning and Data Analysis: Hybridized microarray slides were scanned using the Gene 
Fix 4000B Scanner (Axon Instruments) and the Gene Fix Fro 5.1 software (Axon 
Instruments). The data from each scanned digital image was analyzed using lobion Gene 
Traffic (lobion Stratagene Analysis Software, lobion Informatics LLC, Stratagene, La 
Jolla, CA). Initially, data was normalized to a total 1:1 red to green ratio for the entire 
slide. Data were then filtered based on replicate quality, signal intensity, and signal-to- 
background ratios of 1.2 or higher. An arbitrary cutoff of 1.5 fold upregulation and 1.4 
fold downregulation was used to select genes of interest.
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Semi-Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR):
RNA purification was carried out following the same protocol used for the 
microarray analysis. cDNA synthesis of the RNA was done according to the protocol 
provided in the Superscript III First-Strand Synthesis System for RT-PCR kit 
(Invitrogen). Briefly, 2 pg of RNA was combined with 5 pM oligo(dX)2 o, ImM dNTP 
mix and incubated at 65®C for 5 min followed by 1 min on ice. With the tube on ice, the 
following were added: RT buffer (20 mM Tris-HCl pH 8.4, 50 mM KCl), 5 mM MgClz,
10 mM DTT, 40 U RNaseOUT, and 200 U Superscript III RT. After gentle mixing, 
reactions were incubated for 50 min at 50®C. Reactions were terminated by heating at 
85°C for 5 min and then placed on ice. 2 U o f RNase H were added to each reaction and 
allowed to incubate for an additional 20 min at 37°C. cDNA synthesis reactions were 
either used for PCR immediately or stored at -20°C.
PCR reactions were carried out in a programmable PTC-200 (Bio-Rad, Hercules, 
CA) thermal cycler using Platinum PCR SuperMix (Invitrogen) while following the 
accompanying protocol. ECM l, ODCl, and TUBGl primers were designed using 
PrimerQuest software from Integrated DNA Technologies, Inc. p-actin primers were 
used to amplify actin as an internal control (Maxim Biotech, Inc., South San Francisco, 
CA), and were expected to yield a product of 303 bp. Briefly, reaction tubes contained 
10 ng o f cDNA template, 500 nM of selected primers, and 45 pL of Platinum PCR 
SuperMix (lU  complexed recombinant Taq DNA polymerase with Platinum Taq 
Antibody, 20 mM Tris-HCl pH 8.4, 50 mM KCl, 1.5 mM MgCh, 200 pM dGTP, 200 pM 
dATP, 200 pM dTTP, and 200 pM dCTP). The PCR reactions were cycled as follows: 2
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
31
min at 94°C to activate Taq (1 cycle); 30 sec at 94®C (dénaturation step), 30 sec at 62° 
(annealing step, temperature used for all primer sets) and 1 min at 72°C (extension step) 
for 30 cycles (all primer sets).
After the PCR reaction, PCR products were electrophoresed alongside a 100 bp 
DNA ladder (Promega, Madison, WI) through a 1% (w/v) agarose (Bio-Rad) gel stained 
with ethidium bromide. Images were captured using a Kodak DC290 digital camera and 
optical density values o f PCR products were quantified using Quantity One software 
v.4.2.1 (Bio-Rad). PCR reactions were done in triplicate and statistical analysis was done 
with Prism v4.0 software.
Immunoblot analysis:
Treated SH-SY5Y cells were removed by scraping and subsequently lysed for 30 
min on ice in lysis buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 1% (v/v) Triton X- 
100). Lysate was centrifuged shortly to pellet heavy membranes. Protein concentration 
of the lysate was determined by the BCA method (Pierce, Rockford, IL). All 
immunoblots were done in triplicate.
ECMl immunoblot- 15 pg of protein was loaded onto a 10% PAGE gel (Bio-Rad), 
electrophoresed and transferred to PVDF membrane (Bio-Rad). The membrane was, a) 
blocked with 2% BSA (Calbiochem, La Jolla, CA) in phosphate buffer saline with Tween 
(PBS-T, pH 7.4, Tween 0.1%) for 1 h at room temperature, b) washed in PBS-T for 10 
min, c) incubated with rabbit anti-ECMl (1 ; 1000 in block) overnight at 4°C, d) washed
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2X quickly, IX 15 min in PBS-T, e) incubated with donkey anti-rabbit HRP linked 
(1:10,000 in block) for 1 h at room temp, f) washed 2X quickly, 1X15 min in PBS-T, 
and finally, g) visualized with ECL Plus Western Blotting Detection Reagents (GE 
Healthcare, Piscataway, NJ) using a Fujifilm LAS-3000 imaging system (Fuji Photo 
Film, Valhalla, NY) and Image Gauge v4.22 software.
ODCl immunoblot- Followed exact same protocol as ECMl Western, with a few 
exceptions. 30 pg o f lysate was loaded in each lane and the primary antibody, goat anti- 
ODCl (1:500 in block) was incubated for 1 h at room temp. The secondary antibody was 
horse anti-goat (1:2000 in block).
Ornithine Decarboxylase (GDC) Activity Assay:
ODC activity was quantified using a modification of the procedure described by 
Coleman and Pegg (Morgan 1997). Cell extracts were lysed in a solution of 10 mM Tris- 
HCl, pH 7.5, 2.5 mM dithiothreitol (DTT), and 0.1 mM EDTA (250 pL). Cells were 
frozen and thawed three times followed by centrifugation at 12,000 x gr for 15 min at 4°C 
and then placed on ice. 100 pL of supernatant was combined with 100 pL of lysis buffer 
and a 50 pL aliquot o f assay mix (12.5 pL of IM Tris-HCl, pH 7.5, 5 pL of 2 mM 
pyridoxal 5'-phosphate, 2.5 pL of 250 mM dithiothreitol, 5 pL of 20 mM L-omithine, 2.5 
pL o f L-[1-*'*C] ornithine, and 22.5 pL o f deionized water) in a glass assay tube. The 
reaction tube was immediately closed with a rubber stopper containing a center well 
holding a quarter piece o f a 5.5 cm Whatman filter paper soaked in 1 M NaOH. Tubes
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were allowed to incubate in a shaking water bath for 1 h at 37°C and the reaction was 
then stopped by adding 0.25 mL o f 5 M sulfuric acid through the rubber cap. After a 
further 1 h incubation, the filter paper was removed and placed in 3 mL of scintillation 
liquid plus 25 pL of 17 M glacial acetic acid (to reduce lumex number) and counted in a 
scintillation counter. 30 pL of remaining cell lysate was TCA precipitated and then 
subject to BCA assay to determine protein concentration. Data were calculated as 
nanomoles of CO2  per milligram protein per hour.
Cell Proliferation Assays:
Cell Counting- SH-SY5Y cells were passed into a 6 well plate at 1x10^ cells/well and 
allowed to adhere for 48 h. Cells were exposed to 10 nM PX or acetone control in 
triplicate. Cells were allowed to incubate for 6 days before harvesting. At 6 days post 
treatment, media was removed, cells were washed in PBS, and next, 0.75 mL of trypsin 
was added to each well and plate was incubated for an additional 5 min. 0.75 mL of PBS 
was added to each well and the contents of each well were removed and placed in a 
microcentrifuge tube. 35 pL o f cell/PBS/trypsin solution was combined with 35 pL of 
trypan blue, mixed, placed on a hemacytometer, and counted. Three separate areas of the 
hemacytometer were counted and recorded for each well.
MTT Assay- SH-SY5Y cells were passed into a 96 well plate at 2 different densities (1 
and 3x10'^) in 200 pL o f media/well and allowed to adhere for 48 h. Two different 
concentrations of PX (10 nM and 1 nM) or acetone (control) were added to the cells. For
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each cell density and each concentration of PX, 3 wells o f cells were treated along with 3 
wells o f acetone-treated cells, for a total o f 24 wells treated per experiment. For each cell 
density, the different concentration o f PX-treated cell counts were compared to the total 
acetone treated cell counts (3 wells o f PX vs. 6 wells of acetone for each cell density). At 
96 h post PX treatment, the MTT assay (Roche, Indianapolis, IN) was performed using 
the accompanying protocol. Briefly, 20 pL of MTT labeling reagent (final concentration 
0.5 mg/mL) was added to each well. The plate was incubated in a humidified incubator 
(same as cell culture above) for 4 h following labeling. Next, 100 pL of Solubilization 
solution was added to each well and the plate was again placed in the humidified 
incubator overnight. The plate was read on a microplate reader at 560 nm with a 
reference wavelength of 690 nm.
Materials:
Cell culture media was purchased from ATCC (Manassas, VA). FBS, antibiotics, 
and trypsin were purchased from Invitrogen. Trypan blue, EDTA, L-omithine, and 
pyridoxal 5’-phosphate were all obtained from Sigma (St. Louis, MO). L-[1-^"^C] 
ornithine hydrochloride was purchased from GE Healthcare. The anti-ECMl polyclonal 
antibody was provided by Professor Lurong Zhang at the University o f Roehester. Anti- 
ODC antibody was purchased from Santa Cruz Biotechnology Inc (Santa Cruz, CA).
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Chapter 5
Transcriptional changes in the SH-SY5Y human neuroblastoma cells following 
acute, low-dose exposures to the organophosphate paraoxon
Introduction
Microarray technology allows the rapid and quantitative analysis of gene 
expression patterns within a cell or area of tissue. Microarray allows researchers to 
survey gene expression changes of entire genomes in different species including human, 
mouse, and yeast. The use o f microarray technology in experiments has been applied to 
many different areas o f research including genotyping, development, human disease, 
drug discovery, and notably, the field of toxicology (Afshari et al. 1999; Schena 2003; 
Newton et al. 2004). Within the field o f toxicology, microarray is used as a screening 
tool for the identification of molecular targets and mechanisms of toxicity. A review by 
Vrana et al. states that microarray “enables researchers to identify those genes and their 
products (either single or whole pathways) that are involved in conferring resistance or 
sensitivity to toxic substances” (Vrana et al. 2003).
The SH-SY5Y human neuroblastoma cell line, with an adrenergic neuronal 
phenotype and expression of relatively high levels of AChE and NTE, has been used in 
numerous toxicological studies as well as a model system for OP toxicity testing (Ehrich 
1995; Veronesi et al. 1997; Barber and Ehrich 2001; Hong et ai. 2003). Gene expression 
patterns have also been characterized in SH-SY5Y cell lines using microarray, following 
treatment with a wide variety of compounds including ethanol, nicotine, tunicamycin (an 
inhibitor of glycosylation), and the Parkinson’s disease causing metabolite MPP  ̂(1-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
36
Methyl-4-Phenyl-Pyridinium) (Conn et al. 2002; Dnnckley and Lukas 2003; Hassan et al. 
2003; Reimertz et al. 2003; Hoemdli et al. 2004).
The work presented in this chapter details the transcriptional changes in human 
neuroblastoma cells (SH-SY5Y) following a time-course o f acute, low-dose exposures to 
the organophosphate paraoxon, measured by cDNA microarray. Data analysis of 
genomic changes was further examined using the GoMiner software (available at 
http://discover.nci.nih.gov/gominerA. GoMiner is a tool used to gain insight into the 
biological relevance o f transcriptional changes within an experiment. The findings 
presented in this chapter will help to begin to understand and define the pathways and 
different cellular targets modified by OP exposure.
Results
To assess the extent to which the OP paraoxon (PX) modulates gene expression in 
neuronal cells, transcriptional changes were monitored using an in-house. Human 
Toxicology microarray chip (Mark Pershouse Laboratory, University of Montana) 
containing approximately 1600 different genes. The genes represented on the Human 
Tox chip have defined functions in basic cellular processes as well as roles in specific 
responses to different types of toxic insult. While these genes are not representative of 
the entire genome, they do provide a foundation for certain pathways or targets affected 
by OPs. RNA was isolated from SH-SY5Y neuroblastoma cells treated for 3, 8, and 24 h 
with 10 nM PX or acetone vehicle. Previous experimental data using OPs has come 
under criticism for the unrealistically large amount of OP that was needed to observe any
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significant change in protein levels (Ray and Richards 2001). The documented cases o f 
OP poisoning usually exhibit some degree of cholinergic toxicity, but there are a 
significant number of undocumented cases that are exposed to substantially lower 
concentrations of OP. Although concentrations of OPs in the blood may reach 
micromolar range following a severe poisoning, the target tissues and cellular proteins 
and pathways being perturbed by the OP are most likely due to much lower 
concentrations (Sun et al. 2000). The fact that OPs show low environmental persistence 
due to biodégradation has led to the belief that many o f the toxic effects of OPs are due to 
acute rather than chronic exposures (Casida and Quistad 2004). It was for these reasons 
that a low-dose (10 nM), acute (3, 8, 24 hr) exposure o f PX was used.
The use of cDNA as targets on the microarray chip affords greater ability to 
observe low abundance mRNA’s. However, with the long length o f the cDNA probes 
compared to oligo probes, what is made up in targeting lower abundance mRNA’s is lost 
in specificity. A higher hybridization temperature creates more specificity between target 
and probe, yet reduces the amount o f probe-target hybridizations. For this reason, 
fluorescently labeled cDNA was hybridized with the chip at two different temperatures, 
42° and 50°, each done in duplicate, for a total of four microarray slides per time-point.
On the Human Tox microarray chip, each gene is spotted six times on the slide, with two 
different areas being spotted, and each area done in triplicate. After normalization and 
background reduction, genes of interest were selected using an arbitrary cut-off of at least 
1.5 fold or greater up regulation, 1.4 fold or greater down-regulation, and at least 5 or 
more valid spots of the 24 total spots. While a total of 24 spots were available for each 
gene, the combination of some genes not hybridizing at the higher temperature (loss o f 12
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spots) and the loss o f occasional valid spots due to user manipulation during the 
experiment resulted in the use of 5 or greater valid spots as the cut-off. Microarray data 
analysis revealed a total o f 15,49, and 26 genes up-regulated after 3, 8, and 24 h of 10 
nM PX treatment using these filters, respectively. The number of down-regulated genes 
compared to control was 6, 9, and 7 for each successive time-point. Table 5.1 provides a 
list o f differentially expressed genes following PX exposure.
Table 5.1 Up- and downregulated genes in SH-SY5Y cells after exposure to 10 nM 
PX
Genes marked with a (3,8) showed up- or downregulation at the 3 and 8 h time points 
Genes marked with a (8,24) showed up- or downregulation at the 8 and 24 h time points 
Genes marked with a (3,8,24) showed up- or downregulation at all time points (3, 8, 24 h) 
Genes marked with a (3,24) showed up- or downregulation at the 3 and 24 h time points
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3 h 10 nM PX Upregulated genes
Gene ID Gene nam e Valid Snots Fold Change STDEV Time Points
R34002 ISGF3G 5 2.2 0.68
Interferon-stimulated transcription factor 3, gamma 48kDa
AA099195 GDI2 5 2 0.34
GDP dissociation inhibitor 2
AA033966 CYP2C8 11 1.9 0.43 (3,8,24)
Cytochrome P450, family 2, subfamily C, polypeptide 8
R72075 NRGl 6 1.8 0.6
Neuregulin 1
N62663 KDELR 7 1.7 0.23
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2
AA004204 COL5A2 9 1.65 0.31 (3,8)
Collagen, type V, alpha 2
R78620 CXCR4 13 1.65 0.58 (3,8)
(C-X-C m otif receptor 4
R2324I SOCS2 5 1.6 0.41
Suppressor o f  cytokine signaling 2
W44542 GNAIl 13 1.6 0.44 (3,8,24)
Guanine nucleotide binding protein (G protein), alpha inhibiting activity
polypeptide 1
AA029292 OXTR 8 1.5 0.21
Oxytocin receptor
AAl 00835 RAP80 6 1.5 0.14
Receptor associated protein 80
AI381503 IL5RA 7 1.5 0.32 (3,8)
Interleukin 5 receptor, alpha
H44575 DST 7 1.5 0.25
Dystonin
N79484 ECMl 21 1.5 0.25 (3,8,24)
Extracellular matrix protein 1
T86932 GPR65 15 1.5 0.29
G protein-coupled receptor 65
3 h 10 nM PX Downregulated genes
Gene ID Gene nam e Valid Snots Fold Change STDEV Time Points
AA045178 LIGl 9 -1.7 0.12 (3,8,24)
Ligase I, DNA, ATP-dependent
AA043211 ACSLl 9 -1.5 0.49
Acyl-CoA synthetase long-chain family member 1
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AA242743 XPA 8 -1.5 0.21 (3,24)
Xeroderma pigmentosum, complementation group A 
BG572956 BIRC2 9 -1.5 0.36 (3,24)
Baculoviral lAP repeat-containing 2 
AA046463 DHPS 9 -1.4 0.19
Deoxyhypusine synthase 
AA028080 AKT3 9 -1.4 0.2
V-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)
8 h 10 nM PX Upregulated genes
Gene ID Gene name Valid Spots Fold Change STDEV Time Points
AA033966 CYP2C8 9 3.7 0.41 (3,8,24)
Cytochrome P450, fam ily 2, subfamily C, polypeptide 8 
R78620 CXCR4 14 2.7 0.46 (3,8)
Chemokine (C-X-C motif) receptor 4 
AA055467 ODCl 22 2.4 0.27
Ornithine decarboxylase 1 
AA029766 TAF9 24 2.3 0.3 (8,24)
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associatedfactor,
32kDa
R46574 FCGR2A 10 2.3 0.31 (8,24)
Fc fragment o f  IgG, low affinity Ila, receptor (CD32)
W44542 GNAIl 18 2.3 0.23 (3,8,24)
Guanine nucleotide binding protein (G protein), alpha inhibiting activity 
polypeptide I
W94612 MCM2 22 2.2 0.22
MCM2 minichromosome maintenance deficient 2, mitotin (S. cerevisiae)
AA046039 MYCBP 5 2.2 0.38
C-myc binding protein
N79484 ECMl 20 2.2 0.58 (3,8,24)
Extracellular matrix protein I
AA040600 PRKAGl 5 2.2 0.27
Protein kinase, AMP-activated, gamma 1 non-catalytic subunit 
N95418 FKBP8 11 2.2 0.43
FK506 binding protein 8, 38kDa 
R11631 PAK4 21 2.2 0.33
P2I(CDKNlA)-activated kinase 4 (a family o f  serine/threonine p21-activating 
kinases)
N93133 PML 15 2.1 0.39
Promyelocytic leukemia
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AA03448I M6PR 20 2.0 0.36
Mannose-6-phosphate receptor (cation dependent)
AA047816 MVD 21 2.0 0.2
Mevalonate (diphospho) decarboxylase 
AA044744 SFRS7 24 2.0 0.4
Splicing factor, arginine/serine-rich 7, 35kDa 
W47128 CDK9 20 1.9 0.78
Cyclin-dependent kinase 9 (CDC2-related kinase)
AA004204 COL5A2 11 1.8 0.29 (3,8)
Collagen, type V, alpha 2 
AI381503 IL5RA 7 1.8 0.64 (3,8)
Interleukin 5 receptor, alpha 
AA045751 UBE2A 21 1.8 0.46
Ubiquitin-conjugating enzyme E2A (RAD6 homolog)
AA143571 PRKARIA 23 1.8 0.28
Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific 
extinguisher 1)
N68521 MAP2K2 24 1.8 0.4
Mitogen-activated protein kinase kinase 2 
AA021574 LAMBl 18 1.7 0.6
Laminin, beta I
AA040721 Taxlin 9 1.7 0.31
Taxlin- high molecular weight B-cell growth factor receptor binding 
AA045633 ADFP 9 1.7 0.39
Adipose differentiation-related protein 
AA041538 SRF 8 1.7 0.35
Serum response factor (c-fos serum response element-binding transcription
factor)
AAl 13936 CCNBl 12 1.7 0.15
Cyclin B1
H55985 GSTAl 6 1.7 0.25
Glutathione S-transferase A I
R59864 DUSP6 18 1.7 0.29
Dual specificity phosphatase 6
AA029584 TFF3 7 1.6 0.09
Trefoil factor 3 (intestinal)
AA055478 LAM A4 9 1.6 0.14
Laminin, alpha 4
AA065228 MYLK 7 1.6 0.26
Myosin, light polypeptide kinase
AA076085 STATl 6 1.6 0.12
Signal transducer and activator o f  transcription 1, 91kDa
AAl 56876 TEAD3 6 1.6 0.46
TEA domain fam ily member 3 (transcriptional enhancer fc
H13133 KDELR2 9 1.6 0.19 (8,24)
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2
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H14890 MASTl 6 1.6 0.36
Microtubule associated serine/threonine kinase 1 
H87394 HMMR 11 1.6 0.31 (8,24)
Hyaluronan-mediated motility receptor (RHAMM)
N35079 IQCBl 12 1.6 0.43
IQ m otif containing B1 
N47111 HTR2C 18 1.6 0.44
5-hydroxytryptamine (serotonin) receptor 2C 
N62328 GRM3 12 1.6 0.25 (8,24)
Glutamate receptor, metabotropic 3 
R78776 PTPRK 12 1.6 0.2
Protein tyrosine phosphatase, receptor type, K  
R71212 BMPl 24 1.5 0.22
Bone morphogenetic protein 1 
AA044151 FABP3 6 1.5 0.13
Fatty acid binding protein 3, muscle and heart (mammary-derived growth 
inhibitor)
AA044422 DOXl 6 1.5 0.05
DEAD (Asp-Glu-Ala-Asp) box polypeptide I
T57875 PRKCI 7 1.5 0.29
Protein kinase C, iota
AA056736 RBBP7 12 1.5 0.3
Retinoblastoma binding protein 7
W88506 HMOXl 23 1.5 0.26
Heme oxygenase (de cycling) 1
8 h 10 nM PX Downregulated genes
Gene ID Gene name Valid Spots Fold Change STDEV Time Points
AA101409 SFRS3 6 -1.7 0.26
Splicing factor, arginine/serine-rich 3
AA045178 LIGl 9 -1.6 0.13 (3,8,24)
Ligase I, DNA, ATP-dependent
AAl 26727 HOXA7 7 -1.6 1.45
Homeo box A 7
AA410383 CXCLI3 6 -1.6 0.46 (8,24)
Chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant)
N43826 FYN 9 -1.6 0.49
FYN oncogene related to SRC, FGR, YES (member o f  the protein-tyrosine kinase
oncogene family)
R93550 ALDHIBI 7 -1.6 0.54
Aldehyde dehydrogenase 1 family, member BI
W74710 FALZ 5 -1.6 0.34
Fetal Alzheimer antigen
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R37866 IQGAPl 9 -1.5 0.29 (8,24)
IQ m otif containing GTPase activating protein 1 
AA054546 CYBA 8 -1.5 0.29 (8,24)
Cytochrome b-245, alpha polypeptide
24 h 10 nM PX Upregulated genes
Gene ID Gene name Valid Spots Fold Change STDEV Time Points
N63328 PPP2R2B 23 2.0 0.56
Protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), beta isoform 
W65461 DUSP5 7 1.9 0.29
Dual specificity phosphatase 5 
H72722 MTIB 21 1.8 0.29
Metallothionein IB  (functional)
R52410 NTRK2 10 1.8 0.37
Neurotrophic tyrosine kinase, receptor, type 2 
AA029766 TAF9 21 1.8 0.3 (8,24)
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associatedfactor,
32kDa
N62328 GRM3 10 1.8 0.29 (8,24)
Glutamate receptor, metabotropic 3 
H87394 HMMR 11 1.7 0.51 (8,24)
Hyaluronan-mediated motility receptor (RHAMM)
H13133 KDELR2 7 1.7 0.17 (8,24)
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 
W49497 MMPl 16 1.7 0.6
Matrix metalloproteinase I (interstitial collagenase)
W23995 MSH2 21 1.7 0.37
MutS homolog 2, colon cancer, nonpolyposis type I (E. coli)
R46574 FCGR2A 9 1.6 0.21 (8,24)
Fc fragment o f  IgG, low affinity Ila, receptor (CD32)
R87559 GRIN 19 1.6 0.17
Glutamate receptor, ionotropic, N-methyl D-aspartate 1 
N50949 SEC22L3 24 1.5 0.16
SEC22 vesicle trafficking protein-like 3 (S. cerevisiae)
N79484 ECMl 18 1.5 0.15 (3,8,24)
Extracellular matrix protein I 
R79560 TJPl 24 1.5 0.16
Tight junction protein 1 (zona occludens 1)
R82017 LRPl 19 1.5 0.15
Low density lipoprotein-related protein I (alpha-2-macroglobulin receptor) 
T88776 MAP4K2 24 1.5 0.14
Mitogen-activated protein kinase kinase kinase kinase 2
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W44542 GNAIl 17 1.5 0.25 (3,8,24)
Guanine nucleotide binding protein (G protein), alpha inhibiting activity 
polypeptide 1
AA010576 DHFR 21 1.5 0.17
Dihydrofolate reductase 
AA033966 CYP2C8 20 1.5 0.3 (3,8,24)
Cytochrome P450, fam ily 2, subfamily C, polypeptide 8 
AA046892 DADl 24 1.5 0.09
Defender against cell death 1 
AA056507 IFRDl 22 1.5 0.22
Interferon-related developmental regulator I 
AA059066 ZF 21 1.5 0.19
HCF-binding transcription factor Zhangfei 
H57126 CSFIR 24 1.5 0.2
Colony stimulating factor I  receptor, formerly McDonough feline sarcoma viral 
(v-fms) oncogene homolog
W74060 NR1D2 24 1.5 0.11
Nuclear receptor subfamily 1, group D, member 2 
W76604 RAB28 8 1.5 0.16
RAB2S, member RAS oncogene family 
W78013 MCM3 18 1.5 0.32
MCM3 minichromosome maintenance deficient 3 (S. cerevisiae)
24 h 10 nM PX Downregulated genes
Gene ID Gene name Valid Spots Fold Change STDEV Time Points
AA410383 CXCL13 5 -1.9 0.47 (8,24)
Chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant)
AA054546 CYBA 10 -1.7 0.27 (8,24)
Cytochrome b-245, alpha polypeptide 
R37866 IQGAPl 10 -1.6 0.36 (8,24)
IQ m otif containing GTPase activating protein 1 
AA045178 LIGl 12 -1.5 0.12 (3,8,24)
Ligase I, DNA, ATP-dependent 
AA242743 XPA 12 -1.4 0.23 (3,24)
Xeroderma pigmentosum, complementation group A 
AI088984 IL27RA 7 -1.4 0.4
Interleukin 27 receptor, alpha 
BG572956 BIRC2 12 -1.4 0.22 (3,24)
Baculoviral lAP repeat-containing 2
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Initial microarray data analysis
The data in Table 5.1 represents the list o f genes whose expression were 
considered significantly altered following PX exposure for 3, 8, and 24 h. The validity of 
each gene was initially assessed on the number of valid spots on each of the replicate 
microarray slides. Further analysis was done on each gene by observing the individual 
spots that makeup the data for that gene, including number o f valid spots, fold change, 
and standard deviation (STDEV). The STDEV for each gene was computed using the 
fold changes o f each valid spot, however, if  one or two of the valid spots showed poor 
hybridization, the STDEV increased. Spots that were not considered valid were not 
included in the calculation of STDEV. For this study, the ideal standard deviation for 
each gene should be 0.3 or less. In general, the STDEV’s for the selected genes in Table 
5.1 are less than 0.3. However, due to variation between each slide that occurred from 
user error and because two different hybridization temperatures were used, some of the 
genes showed an unfavorable STDEV (greater than 0.3). Thus, each gene (including 
genes with a higher than desirable STDEV) that showed initial promise as being an up- or 
downregulated gene was viewed and analyzed individually to ensure that the majority o f 
valid spots showed a uniform fold change. Genes that did not present a majority of valid 
spots as being up- or downregulated were discarded from the list.
Analysis of the 10 nM PX time-course showed the number o f genes upregulated 
increased significantly from the 3 to 8 h time-point. After the 8 h time-point, a small 
decrease in the number of genes upregulated was observed. Due to the low concentration 
of PX used, one would expect to see a sharp increase in the number of affected genes 
after the initial insult by PX followed by a decrease in changed gene number as the cell
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
46
moves back toward homeostasis. This trend was observed for upregulated genes over the 
24 h time-course and is shown graphically in figure 5,1.
Figure 5.1
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Figure 5.1. Significant changes in gene expression of SH-SY5Y cells following 
exposure to 10 nM PX. Genes listed show at least a 1.5 fold increase and -1.4 fold 
decrease compared to control. Total numbers o f upregulated genes show a large increase 
from the 3 to 8 h time point with a modest recovery o f normal phenotype by 24 h.
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The number of down-regulated genes was similar in number at all time-points.
The downregulated genes were also much smaller in number compared to upregulated, 
but this has been observed in other toxicology microarray results (Rogers et al. 2004). A 
few genes were affected at all three of the time-points. They included upregulated genes 
Cytochrome P450, family 2, subfamily C, polypeptide 8  (CYP2C8), Extracellular matrix 
protein 1 (ECMl), and Guanine nucleotide binding protein (G protein), alpha inhibiting 
activity polypeptide 1 (GNAIl) and the downregulated gene Ligase I, DNA, ATP- 
dependent (LIGl). A number of genes also showed significant fold changes in two o f the 
three time-points. Three genes were upregulated in both the 3 and 8  h time points, while 
there were 5 genes that showed greater than 1.5 fold change in both the 8  and 24 h time 
points. Interestingly, using a cutoff o f 1.4 fold upregulation increased the number of 
genes that showed upregulation in both 8  and 24 h fi-om 5 genes to 18 genes. Even as the 
cell returned to stasis, PX was continuing to modulate a considerable number of genes.
While simple investigative conclusions can be made with the vast amount of 
microarray data, the question remains, what the hell does it all mean? Initial assumptions 
about the toxic effect of PX can be made by simply grouping the list of genes into general 
categories such as “cell cycle”, “structural”, or “transcription factors”. However, 
individual genes and their protein products have been shown to exhibit more than one 
molecular function as well as being involved in many biological processes within a cell. 
Classifying each gene into one category and trying to make hypotheses about what PX is 
doing in the cell can result in a shortsighted or incorrect view of the toxic effect.
The ability to turn an extensive amount of gene (or protein, etc) data into 
biologically relevant and understandable data has been addressed by a number of groups
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(Vrana et al. 2003). The Gene Ontology (GO) project was initiated so as to develop a set 
o f controlled and structured vocabularies to explain genes, gene products, and sequences 
for the science community (Ashbumer et al. 2000; (GO) 2006). The ongoing project 
continues to develop and update the vocabulary as new scientific discoveries are made. 
“The GO project provides an ontological annotation system that enables biologists to 
infer knowledge from large amounts o f data” ((GO) 2006). The systematic language used 
in describing each of the genes and/or gene products is comprised of information in three 
key areas shared by all organisms; molecular function, biological process and cellular 
component. The use of this functional information in combination with each of the genes 
showing differential transcriptional regulation can help emphasize the biological 
processes or pathways being modulated within an experiment. A number o f programs 
have now been developed to help facilitate and streamline the interpretation o f 
microarray data using the GO database. Included in this next section is an interpretation 
o f the cDNA microarray data using the GoMiner software program.
Functional analysis of microarray data
GoMiner is a free program package that separates —omic data into biologically 
coherent categories using the GO database (Zeeberg et al. 2003). The user enters a list of 
all of the genes from the microarray slide along with a list o f genes that were 
experimentally found to be changed in one way or another (up- or downregulated). The 
GoMiner output displays the total number of genes from the microarray slide associated 
with each of the specific GO categories including molecular functions, biological 
processes and cellular components. Underneath each of the category headings is the list 
of genes that were up- or down regulated that are associated with that category as
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described by each gene’s ontology. Certain differentially-expressed genes can be located 
in numerous categories within molecular functions or biological processes. The GoMiner 
output also lists a number describing the relative enrichment (or depletion) o f a certain 
category with respect to the marked genes as well as a two-sided /?-value from Fisher's 
exact test. The enrichment number starts at one (no enrichment or depletion) and moves 
up or down depending on the relative enrichment or depletion o f the marked genes within 
each category. The />-value takes into account the number o f total genes (from the user’s 
microarray slide) involved in each category and the number o f marked genes in the exact 
same category that are either up- or down regulated from the experiment. The null 
hypothesis for each category’sp-value states- there is no difference between the 
proportion of flagged genes that fall into the category and the proportion o f flagged genes 
that do not fall into the category. In other words, to reject the null hypothesis and 
observe a significant p-value means the number of flagged genes within a certain 
category is significant and not due to chance. A representative GoMiner output table is 
shown in figure 5.2.
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Figure 5.2. A representative GoMiner output displaying GO categories under 
biological processes and corresponding up- and down regulated genes. The down
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arrows (green) are downregulated genes, while the up (red) arrows are upregulated. The 
numbers before the p-value are the relative enrichments for the up- and down regulated 
genes.
Using the GoMiner software, the list o f approximately 1600 genes from the 
Human Tox Microarray Chip were loaded into the program. In order to gain an overall 
insight into the action of PX on the cell, all o f the up- and downregulated genes from the 
three time points were uploaded simultaneously. Also, because of the limited number of 
up- and downregulated genes in each time point, and the large number of GO categories, 
the use of all genes from all time points at one time would result in a more statistically 
significant assessment o f altered biological processes. Data was obtained for the up- and 
downregulated genes in all three areas o f GO, molecular functions, biological processes, 
and cellular components. The GO database defines molecular functions as any activity, 
such as binding, transcription, or receptor, at the molecular level. Biological processes 
are a series o f events that include one or more molecular functions in order to achieve the 
biological process. The ensuing discussion will focus primarily on the biological 
processes in the cell that show differential gene transcription levels following PX insult.
Analysis of the GoMiner data resulted in eight biological processes showing 
induction of genes associated with those processes following PX exposure. These 
processes include cell communication, phosphorus metabolism, cellular proliferation, 
cellular lipid metabolism, cellular transport, cell differentiation, cell cycle, and 
cytoskeleton organization and biogenesis. The categories in bold are the broad category 
headings and are followed by a discussion of genes affected within the category and/ or
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subcategories. An enrichment value of 0.0 and corresponding p value of 1.00 means no 
genes were up- or downregulated within that group.
Genes involved in cell communication (upregulated genes, relative enrichment 1.24, 
p=0.05, downregulated genes 1.14, p=0.41):
The largest group of upregulated genes was represented by cellular 
communication processes (437 total genes from Human Tox Chip involved in this 
process, relative enrichment o f 1.24 for upregulated genes, p-value 0.05, relative 
enrichment o f downregulated genes 1.14, p=0.41). This is a broad group that contains 
many subcategories and describes such pathways as cell-cell signaling and signal 
transduction. The signal transduction subcategory (404 total genes from Human Tox 
Chip) showed a p-value of 0.03 for upregulated genes and a relative enrichment of 1.31. 
Among the genes located in this category were Cyclin-dependent kinase 9 (CDK9), 
Colony stimulating factor 1 receptor (CSFIR), Chemokine receptor 4 (CXCR4), Guanine 
nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 (GNAIl),
G protein-coupled receptor 65 (GPR65), Interleukin 5 receptor, alpha (IL5RA), P21- 
activated kinase 4 (PAK4), and Protein phosphatase 2, regulatory subunit B, beta isoform 
(PPP2R2B). Sub-categories of signal transduction that contained upregulated genes 
included cell surface receptor linked signal transduction (relative enrichment of 
upregulated genes 1.39, p=0.08), G-protein coupled receptor protein signaling pathway 
(enrichment of upregulated genes 1.62, p=0.16), intracellular signaling cascade 
(enrichment o f upregulated genes 1.32, p-0.12, enrichment of downregulated genes 1.47 
p=0.28), and protein kinase cascade (up genes 1.45, p=0.18, down genes 1.72, p=0.33).
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(For a full list o f genes up- or down regulated within each category and subcategory, see 
appendix A.) Signal transduction at the cellular level refers to the movement of signals 
from outside the cell to inside as well as intracellular signaling. The signal can be a 
simple movement of ions in and out o f the cell through receptors or channels that can 
change electrical potentials and in turn propagate a signal through the cell (Alberts 2002). 
Signal transduction can also be a more complex pathway involving the coupling of 
ligand-receptor interactions to many intracellular events. These events include 
phosphorylations by tyrosine kinases and/or serine/threonine kinases. Protein 
phosphorylations play a critical role in signal transduction and can also change enzyme 
activities and protein conformations. The eventual outcome o f signal transduction is an 
alteration in cellular activity and changes in the program of genes expressed within the 
responding cells. Phosphorylation is a critical regulator of signal transduction and the 
differential transcription o f genes involved in signal transduction following OP exposure 
proposes an interesting hypothesis. PX might be interfering and/or disrupting different 
signaling cascades in the cell through unregulated phosphorylation of signaling cascade 
(i.e. protein kinase) targets.
Genes involved in phosphorus metabolism (upregulated genes, relative enrichment 
1.49, p=0.04, downregulated genes 0.78, p=0.75):
The second major group of target genes included genes involved in the 
phosphorylation and dephosphorylation o f proteins. Many o f these genes generate 
protein products that are important in signal transduction. The ability of PX to interfere 
with the signal transduction pathways by phosphorylation correlates well with PX 
modulation of genes involved in the phosphorylation and dephosphorylation of signaling
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
54
cascades. Two subcategories of phosphorus metabolism contained nearly all of the 
changed genes. The first subcategory is protein amino acid dephosphorylation 
(upregulated genes 1.37, p=0.38) which included the genes Dual specificity phosphatase 
6  (DUSP6 ), upregulated at the 8  h time point, and Dual specificity phosphatase 5 
(DUSP5), which was upregulated at the 24 h time point. The second subcategory is 
protein amino acid phosphorylation (upregulated genes 1.48, p=0.08, downregulated 
genes 1 .0 0 , p=0.62) that was represented by a large number o f upregulated genes 
involved in signal transduction. These genes included Protein kinase C (PRKCI), Protein 
kinase, cAMP-dependent, regulatory, type I, alpha (PRKARIA) and Mitogen-activated 
protein kinase kinase 2 (MAP2K2), all upregulated at the 8  h time point and Mitogen- 
activated protein kinase kinase kinase kinase 2 (MAP4K2) which was upregulated at the 
24 h time point. The inclusion o f this biological process lends support to the idea that PX 
is phosphorylating targets in addition to AChE.
Genes involved in cell proliferation (upregulated genes 1.20, p=0.31, downregulated 
genes 0.00, p=1.00);
Cellular proliferation occurs by way of a complex collection of genes, proteins, 
and signaling cascades that are stimulated by any o f numerous types of growth factors 
and stimulators. A considerable number of genes involved in cell proliferation were 
upregulated in response to PX throughout the 3, 8 , and 24 h PX exposure time. They 
included Mannose-6 -phosphate receptor (M6 PR), Interleukin 5 receptor, alpha (IL5RA), 
and Low density lipoprotein-related protein 1 (LRPl). Further analysis of genes 
associated with cell proliferation noted both Ornithine decarboxylase (ODCl) and ECMl 
as genes involved with proliferation but that were not included on the GoMiner list. The
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majority o f OP studies measuring ceil proliferation after OP exposure show decreases in 
proliferation after a toxic dose (high concentration, micro- to millimolar) of OP (Mileson 
et al. 1998; Carlson et al. 2000; Guizzetti et al. 2005). However, studies have not been 
done correlating low dose OP exposure and cell proliferation. The hypothesis that low- 
level exposure to OP’s is implicated in cancer development (McDuffie 1994; Fritschi et 
al. 2005; Gwinn et al. 2005) could possibly be supported by the upregulation o f genes in 
this group.
Genes involved in cellular lipid metabolism (upregulated genes 1.57, p=0.21, 
downregulated genes 1.49, p=0.50);
Members of this group were divided into two subcategories o f cellular lipid 
metabolism, fatty acid metabolism (upregulated 2.26, p=0.14, downregulated 3.57, 
p=0.25) and lipid biosynthesis (upregulated 4.02, p=0.01). The majority o f genes in this 
biological process were all upregulated during the 8  h time point. However, this group 
illustrates a possible problem in using the p values firom GoMiner in determining whether 
or not there is a significant change to a certain biological process. The subcategory of 
lipid biosynthesis is made up of a possible 15 genes from the Human Tox Chip. Only 
two of these genes showed an upregulation, yet this resulted in a p value o f 0.01. When a 
chip is designed that carries only a small number o f genes within a certain category, a 
smaller number of up- or downregulated genes is needed to produce a significant p value. 
Caution should be used in interpreting biological classes seemingly affected by 
experimental treatment in relation to the types of genes that are contained on the 
microarray chip. This being said, the inhibition o f carboxylesterases (esterases involved 
in cholesterol homeostasis and fatty acid metabolism, (Redinbo and Potter 2005)) by PX
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might have secondarily caused the upregulation of these genes involved in cellular lipid 
metabolism.
Genes involved in cellular transport (upregulated genes 1.36, p=0.07, downregulated 
genes 0.61, p=0.87):
Cellular transport is another broad biological process that encompasses many 
different types o f transport. Cellular transport can involve the movement o f ions, 
electrons, chemical compounds, lipids, and proteins, within and in and out o f the cell as 
well as genes involved in the regulation of cell transport. A significant number of genes 
were shown to be part o f two different subcategories of cell transport. The first 
subcategory is intracellular protein transport (upregulated genes 1.46, p=0.22) and 
contained KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 
(KDELR2), that was upregulated in the 8  and 24 h time point, and Mannose-6 -phosphate 
receptor (M6 PR), a gene that is also shown to be involved in cellular proliferation. The 
second subcategory of cellular transport shown to have differentially transcribed genes 
was vesicle mediated transport (upregulated genes 2.74, p=0.01). The three genes listed 
by GoMiner for this biological process were SEC22 vesicle trafficking protein-like 3 
(SEC22L3, 24 h), GDP dissociation inhibitor 2 (GDI2, 3 h), and Protein kinase C 
(PRKCI, 8  h). Vesicle mediated transport could be essential to cell survival through the 
removal of PX inhibited proteins or in the removal of PX alone.
The genes associated with cell differentiation (upregulated genes 1.23, p=0.25, 
downregulated genes 0.45, p=0.91), cell cycle (upregulated genes 1.08, p=0.43, 
downregulated genes 0.78, p=0.75), and cytoskeleton organization and biogenesis
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(upregulated genes 1.55, p=0.16, downregulated genes 0.00, p=I.OO) can be viewed in 
appendix A.
Discussion
In this analysis we used Human Tox cDNA microarrays to zinalyze transcriptional 
changes during low-level, acute PX exposure in human SH-SY5Y neuroblastoma cells. 
Exposing the cells at three different time points (3, 8 , 24 h) resulted in an increase of 
upregulated genes from the 3 to 8  h time point and a modest decrease of altered genes 
from the 8  h to 24 h time point. The number of downregulated genes was considerably 
less than upregulated genes and did not show a change in gene numbers throughout the 
time course. The majority of differentially altered genes (Table 5.1) showed minor but 
significant fold changes in the range of 1.5 and 2.0 for upregulated genes and -1.4 and -
2 . 0  for downregulated genes.
Further analysis o f genes was performed using the Gene Ontology database and 
the software program GoMiner. GoMiner compares the up- and downregulated genes 
from an experiment to the total genes from the microarray chip and groups the altered 
genes into biological processes or molecular functions depending on the unique 
ontologies of each gene. GoMiner produced eight different biological processes that PX 
might be modulating after exposure. These different processes involving up- and/or 
downregulated genes from the microarray experiments include cell communication, 
phosphorus metabolism, cellular proliferation, cellular lipid metabolism, cellular 
transport, cell differentiation, cell cycle, and cytoskeleton organization and biogenesis. A
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considerable number o f upregulated genes were grouped into cell communication, 
phosphorus metabolism, and cell proliferation.
Two recent studies have also investigated gene expression patterns following OP 
exposure using microarray. Changes in gene expression were measured in rats injected 
with sarin at an early time point of 15 min (0.5 x LD5 0) and a later time point o f 3 months 
( 1  X LD5 0), using a 1200 oligo gene chip geared toward functional and structural groups 
relevant to the nervous system (Damodaran et al. 2006). The early time point identified 
genes involved in ion channel, cytoskeletal, cell adhesion molecules, transporters, and G- 
protein coupled receptors. At three months, up- and downregulated genes were classified 
as calcium channel and binding proteins, cytoskeletal and cell adhesion molecules, and 
GABAergic signaling molecules. Differential gene expression has also been measured in 
human mammary epithelial cells exposed for 6  and 24 h to low concentrations (0.2 
mg/0.1 m^> o f malathion (Gwinn et al. 2005). Genes showing differential expression 
after malathion treatment were found to be implicated in carcinogen and steroid 
metabolism, DNA replication, and cell cycle replication. These papers and the work 
presented in this chapter lend support and continue to build on the hypotheses that OPs 
target non-AChE-associated cellular pathways and further our understanding of the 
mechanisms of cellular toxicity.
Microarrays allow measurement and characterization of entire genomes and 
gene expression changes in a single experiment (Newton et al. 2004). However, due to 
the variability and possible error involved in microarray experiments, care must be taken 
in performing the experiment as well as confirmation of microarray gene changes by a 
secondary method. Possible sources of error include handling of RNA during isolation.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
59
variable amounts o f fluorescent probe added to the RNA, uniformity during the spotting 
of the microarray chip (unequal amounts of cDNA), problems during hybridization 
and/or washing (too much specific probe removed or too little non-specific probe 
removed), and error in the data acquisition and analysis. Care was taken to minimize 
error at each step, such as measurement of RNA after isolation (260/280 ratio), and 
measurement o f fluorescent labeling using the Nanodrop spectrophotometer. However, 
the possibility of error still exists. Gene changes should be confirmed at the RNA and/or 
the protein level. The confirmation of one-gene-at-a-time complements the discovery 
role of the microarray methodology and ensures greater certainty in the microarray results 
(Vrana et al. 2003). The work presented in the next chapter chronicles the experiments 
done to confirm certain genes found to be differentially expressed by cDNA microarray.
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Chapter 6
Confirmation of microarray data by semi-quantitative RT-PCR, western 
immunoblot and radioactive enzyme assay
Introduction
The power o f microarray technology lies in the ability to monitor and characterize 
an extremely large number o f genes and affords the possibility to identify novel genes 
involved in pathophysiological signaling pathways (Hoemdli et al. 2004). The increased 
power of microarray is accompanied by amplified possibilities of errors and false 
positives. Increased attention to detail during microarray experiments as well as careful 
experimental design is imperative for successful results. However, due to the relatively 
early development o f the technology and potential for false positives among the 
thousands of tested genes, confirmation o f individual genes at the mRNA or protein level 
must accompany microarray data (Vrana et al. 2003).
Certain limitations are inherent in microarray experiments and are important to 
consider when analyzing the data (Vrana et al. 2003). First, microarrays measure relative 
amounts of RNA and not absolute amounts. Furthermore, cDNA microarrays are not 
very specific due to the length of the spotted target cDNAs (generally 500-2000 base 
pairs). This problem has been somewhat rectified with the use of oligos (25-50 bp) in 
place of cDNAs, however both cDNAs and oligos are not able to differentiate between 
alternatively spliced transcripts o f the same gene or highly homologous members of the 
same gene family. Another challenge in using microarray is that certain assumptions are 
being made about the cellular targets, mechanisms and pathways being affected by a
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certain treatment, yet the microarray is measuring an intermediate step, the mRNA levels, 
and not the levels o f functional protein product. Once an mRNA is translated into a 
protein (if at all), many different post-translational modifications occur that regulates 
function o f a protein. For these reasons and more, it is critical to experimentally confirm 
certain genes from the microarray data.
In this chapter, the cDNA microarray results will be attempted to be validated 
through confirmation o f certain genes at the mRNA, protein, and enzyme activity level. 
These experiments will be carried out using semi-quantitative reverse transcription 
polymerase chain reaction (semi-quantitative RT-PCR) to make measurements at the 
RNA level, immunoblot to characterize genes at the protein level, and enzyme assays for 
analysis into whether transcriptional changes equate into differences in enzyme activity.
Results
Four specific genes were chosen to validate the microarray data. Two genes were 
upregulated (the specific reasons for choosing these two genes and further information 
about the genes will be explained more thoroughly in the following chapter). Ornithine 
decarboxylase 1 (ODCl, upregulated 2.4 fold, 8 h time point), and Extracellular matrix 
protein 1 (ECMl, upregulated 1.5, 2.2, and 1.5, at the 3, 8, & 24 h time points 
respectively); one gene was chosen as an internal control that showed no fold change at 
any of the time points in the microarray data, y-Tubulin 1 (TUBGl); and the fourth gene 
was P-actin (BA), a standard housekeeping gene used as an internal control for the RT- 
PCR (Bustin 2000; Meadus 2003), that was not a target cDNA on the microarray chip.
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Semi-quantitative RT-PCR
Individual gene mRNA levels were determined using semi-quantitative RT-PCR. 
The optimal annealing temperatures and the linear range for cycle number and quantity of 
template for each gene were determined empirically prior to comparing transcript 
amounts of PX and control treated mRNA. All genes characterized by RT-PCR were 
detected in the SH-SY5Y cells. Primers used in the PCR reactions are shown in Table
6.1. Following the RT-PCR reactions, PCR products were electrophoresed with ethidium 
bromide and optical densities of the resulting bands were measured and analyzed. Figure
6.1 shows the results o f the semi-quantitative RT-PCR, comparing the optical density 
(OD) of the PX-treated transcript and the OD of the control-treated transcript.
Analysis of the RT-PCR data revealed no significant change between mRNA 
levels in PX-treated cells and mRNA in control-treated cells at any of the time points for 
any o f the genes, compared to TUBGl and P-actin controls. While elevated levels of PX 
transcript seem to be evident at the 8 h time point, they were also apparent in both the 
TUBGl and P-actin controls, indicating an increased amount of total mRNA in the 8 h 
PX sample compared to the 8 h control mRNA.
Interestingly, an unidentified band appeared in all of the electrophoresed ECMl 
PCR reactions. The expected bp size of the ECMl transcript is 547 bp, yet in every 
reaction, another band was detected, approximately 100 bp above the expected band, 
creating a doublet. Gene sequence and primer analysis o f ECMl ruled out contamination 
with genomic DNA as well as the possibility of the band being one of the known splice 
variants. ECMl is a relatively newly discovered gene, with the mouse gene first being
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cloned in 1994 and the human homologue isolated in 1997 (Chan 2004). There are 
currently three known splice variants o f ECMl (ECMl a, ECM lb, and ECMlc) showing 
differential expression (Fujimoto et al. 2005). This being said, the possibility of a novel 
splice variant that has yet to be characterized is reasonable. Calculations of the optical 
density o f the ECMl doublet showed differential expression compared to the four genes 
presented in Figure 6.1. Similar expression of mRNA levels between PX- and control- 
treated cells were seen at the 3 and 8 h time points, yet the 24 h time point showed an 
approximately 1.3 fold increase of PX over control, factoring in the TUBGl and p-actin 
controls. The mRNA levels o f the second unidentified ECMl band are shown in figure
6.2, However, due to the scope of the project, further analysis of this uncharacterized 
doublet was not done.
Immunoblot analysis
To validate the mRNA changes characterized by the microarray results, SH- 
SY5Y cells were analyzed by immunoblot for changes in ECMl and ODCl protein 
levels following exposure to PX. Equal amounts of protein lysate were analyzed using an 
antibody to ECMl that was provided by Professor Lurong Zhang at the University of 
Rochester, and a commercially available antibody against ODCl. After probing with the 
primary antibodies, membranes were stripped and re-probed for actin to ensure equal lane 
loading. Protein analysis was done with cells treated with 10 nM PX or acetone vehicle 
for 6, 12, 24 and 48 h. Optimal antibody and lysate concentrations were determined 
empirically prior to final experiments
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
64
A significant increase in ECMl protein level was observed at the 12 and 24 h 
time points (Figure 6.3). ECMl showed upregulation o f mRNA expression at the 3, 8, 
and 24 h time points in the microarray data. Protein expression of ECMl was elevated at 
the 12 h time point and was maintained through the 24 h time point followed by a return 
to control levels by 48 h. Protein analysis of ODC1 was done in a similar fashion as 
ECM l. Results from the immunoblots showed no statistically significant changes in 
ODC 1 protein levels from 6 h to 48 h (Figure 6.4)
ODCl enzyme activity assay
ODC 1 shows variable amounts of mRNA, protein and activity levels that do not 
always correlate within an experiment. Studies have shown minimal changes in mRNA, 
yet large inductions o f protein level and even larger increases in enzyme activity (Lin et 
al. 2002). Other studies have observed changes in mRNA level and no changes in protein 
and activity (Klekner et al. 2001) while another study found all three to closely correlate 
(Mohan et al. 1999). For this reason, very small changes in mRNA as observed in the 
microarray data (but not yet confirmed by RT-PCR or immunoblot) might affect the 
activity of the enzyme. PX may induce a small upregulation o f the gene (as seen by 
microarray) and/or is acting directly on the ODCl protein to modulate enzyme activity. 
ODCl enzyme activity was measured following PX exposure using a modified 
radioactive enzyme assay (Morgan 1997). Activity of ODCl showed no statistically 
significant differences between PX and control treated cells (Figure 6.5).
In general, in-vitro experiments measuring ODCl enzyme activity after treatment 
with some type of compound use an average exposure time of 3 h. Measurements for this
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experiment were done from 4 h up until an 8 h time point, the same time an increase in 
mRNA was shown by microarray. However, it is believed modulated protein levels of 
ODCl are always accompanied by uniform changes in enzyme activity (Lin et al. 2002), 
which is consistent with the data presented in this chapter.
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Table 6.1 Primer sequences for semi-quantitative RT-PCR
GENE
ODCl
ECMl
TUBGl
p-Actin
CYP2C8
LRPl
HMOXl
PRIMER SEQUENCES
5’- CTG CTT GAT ATT GGC GGT GGC TTT -3’ (forward) 
5’- TCA ACA ATC CGA TCG AGG CCA TCA -3’ (reverse) 
Expected product size = 413 bp
5’- ATC TGC CTT CCT AAC CGT CAG CAT -3' (forward) 
5 ’- AGG CCT TCC ATG TAC AGG TGT GAT -3’ (reverse) 
Expected product size = 547 bp
5’- TAG AGG GCT TTG TGC TGT GTC ACT -3’ (forward)
5 , TGA CCA TGG CGA TGT AGC AGT -3’ (reverse)
Expected product size = 573 bp
Expected product size = 303 bp
(Maxim Biotech, Inc., South San Francisco, CA)
5’- ATC AGT GTA AGG CAT GTG GCT CCT -3’ (forward) 
5’- AAG AGG AGC ATT GAG GAC CGT GTT -3’ (reverse) 
5’- TAC ACA ATC TTC CGG TCT GTG CCA -3’ (forward) 
5’- TCA TCT ACT TTG CCG ACA CCA CCA -3’ (reverse) 
5’- CTT GAA CTT GGT GGC ACT GGC AAT -3’ (forward) 
5’- AGG AGA TTG AGC GCA ACA AGG AGA -3’ (reverse)
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Figure 6.1
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Figure 6,1 Semi-quantitative RT-PCR of ODCl, ECM l, TUBGl, and B-actin genes
at 3 ,8 , and 24 time points. Transcripts measured at each time point were done in 
triplicate using lOng of template and 30 cycles o f PCR. Graph is representative of two 
experiments, each performed in triplicate, carried out with different sets of cDNA.
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Figure 6.2. mRNA levels of ECM l unidentified 2”** band. Transcripts measured at 
each time point were done in triplicate using lOng o f template and 30 cycles of PCR. 
Graph is representative of two experiments performed with different sets of cDNA.
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Figure 6.3
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Figure 6.3. Immunoblot analysis of EC M l following lOnM PX exposure. Optical 
densities (CD) were measured for each band and are graphically represented as (PX CD / 
actin CD) / (control CD / actin CD). Data is from three independent experiments. 12 
and 24 h time points are statistically significant fold changes at the level of * p < 0.05 
(unpaired t test).
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Figure 6.4
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Figure 6.4. Immunoblot analysis of ODCl following 10 nM PX exposure. Optical 
densities (CD) were measured for each band and are graphically represented as (PX CD / 
actin CD) / (control CD / actin CD). Each time point is representative of three 
independent experiments. There were no significant changes between any of the time 
points.
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Figure 6.5
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Figure 6.5. OD Cl enzyme activity following exposure to 10 nM PX, Activity o f 
ODCl was measured after 4, 5.5, and 8 h of PX exposure. Data represents experiments 
done in duplicate for each time point. The positive control was a 3 h media change prior 
to harvesting the cells (shown to strongly increase ODCl activity, (Mattsson et al. 1984)).
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Discussion
The ability o f microarray technology to characterize an immense number of gene 
expressions in one experiment increases the possibility o f error within the experiment, 
namely the observation o f false positives. For this reason, the validation of microarray 
data must be done by confirming gene changes by other accepted, well established 
techniques. This can include confirming changes from microarray data at the RNA 
and/or protein level. The validation o f microarray data presented in Chapter 5 was 
addressed by three different methods which included semi-quantitative RT-PCR, western 
immunoblot, and a radioactive assay to measure enzyme activity.
The mRNA expression levels of four genes (ECM l, ODCl, TUBGl, and (3-actin) 
were measured using semi-quantitative RT-PCR. The results from the experiments 
showed no change in expression levels in each of the three time points for TUBGl 
(expected) as well as no change in expression levels of ECMl and ODCl (not expected, 
both genes showed upregulation in the microarray data). Furthur RT-PCR analysis 
measured PX and control treated cells mRNA expression o f Cytochrome P450, family 2, 
subfamily C, polypeptide 8 (CYP2C8), Low density lipoprotein-related protein 1 (alpha- 
2-macroglobulin receptor) (LRPl), and Heme oxygenase (decycling) 1 (HMOXl).
Again, no changes in expression levels between PX and control treated cells was 
observed. There could be any number of reasons the semi-quantitative results did not 
correlate with the microarray data. Because the gene fold changes in the microarray data 
were modest, the ability to observe the same modest changes through other methods 
becomes difficult and requires greater sensitivity and precision. The use of semi-
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quantitative RT-PCR (sqRT-PCR) has drawn criticism as not being a sensitive enough 
method to monitor small changes in mRNA expression (Rajeevan et al. 2001). There is 
also the possibility that the cDNA microarray targets hybridized certain known and/or 
unknown spice variants, or gene family homologues, of these upregulated genes and 
these splice variants (or homologues) were not enriched using the chosen PCR primers. 
The increased expression of the unidentified 2"** band of ECMl at 24 h somewhat 
supports this hypothesis. Semi-quantitative RT-PCR can show variability in the results 
and is prone to error during the many steps firom isolated RNA to electrophoresed PCR 
products (Brunner 2004). In some cases, the up- or downregulated genes fi*om the 
microarray data are false positives and would therefore show no change by RT-PCR.
The use of quantitative real-time RT-PCR has alleviated many o f these problems and 
would have been a better choice for confirming microarray data. In addition to using 
semi-quantitative RT-PCR, upregulated genes ECMl and ODCl were also monitored for 
increased protein levels.
Immunoblot analysis o f ECMl and ODCl confirmed the upregulation of the 
ECMl gene and gave further proof to the possibility ODCl was a false hit. ECMl 
protein expression showed increased levels at 12 and 24 h post PX exposure. The 
microarray data shows a slight upregulation at 3 h (1.4 fold), followed by a substantial 
increase at 8 h (2.2 fold), and then a decrease at 24 h to 1.5 fold which correlates well 
with the protein expression. ODCl protein expression did not change at any time point 
after PX exposures. Due to the variability in expression levels of ODCl gene, protein, 
and enzyme activity discussed above, we wanted to make sure to analyze all possible
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areas to either confirm or rule out ODCl as a hit or false positive, and so ODCl was 
further characterized with respect to enzyme activity.
The radioactive assay used to measure ODCl activity showed no statistically 
significant increase or decrease in enzyme activity after PX insult. Initial failures in 
confirming ODCl upregulation by semi-quantitative RT-PCR and western blot were 
attributed to two different factors. The first was that ODCl is a highly regulated enzyme 
and has a very short half-life, ranging from minutes to an hour (Lin et al. 2002). The 
second reason is immortal cells express higher levels of ODC protein and exhibit 
elevated enzyme activity compared to normal tissue or primary cell lines (Hu et al. 2003). 
We believed the short half life in addition to high levels of ODCl protein and activity 
(SH-SY5Y is an immortal cell line) was confounding our ability to measure small 
differences in either RNA or protein levels. However, after confirming no change in 
enzyme activity levels, we were confident in assuming ODCl was a false positive (no 
change in RT-PCR, immunoblot, enzyme activity) and did not warrant consideration as 
an upregulated gene in response to PX. The work done on ODC 1 emphasizes the 
importance in confirming up- and dovraregulated genes following microarray 
experiments.
While it is o f utmost importance to confirm individual genes from the microarray 
data, the original hypothesis was to identify and characterize pathways, protein targets, or 
biological processes that are modulated in some way by the OP paraoxon. The next 
chapter specifies the reasons why ECMl and ODCl were chosen as genes to confirm and 
details the work done to support the hypothesis that 10 nM PX induces cellular 
proliferation.
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Chapter 7
Characterization of the induction of cellular proliferation by acute, low-dose
paraoxon exposure
Introduction
Microarray technology allows the user to simultaneously monitor thousands of 
gene expression levels in one experiment. The next step is organizing the extensive 
amounts of microarray data into intelligible biological data that sets forth different ideas 
of what all the gene changes mean. The interpretation of this data is often the most 
difficult step of a microarray experiment.
There are a number of programs available that analyze the different up- and 
downregulated genes and attempt to produce different pathways or biological processes 
that might be modulated in some way. While the organization o f the microarray data into 
the different pathways is extremely helpful, it does not establish proof of causation. 
Nevertheless, the organization of this data is advantageous in developing hypotheses 
about the nature of the treatment and its effect on a biological or cellular system. The 
next step after carefully reviewing and evaluating the meaningful microarray data is to 
design an appropriate set of experiments to test a hypothesis.
The purpose of the present research was to test the hypothesis that the OP PX 
modulated / altered / blocked a unique or novel set of protein targets or specific cellular 
pathways following exposure. Microarray data from SH-SY5Y cells treated with lOnM 
PX was further characterized using the GoMiner software to try and identify these 
affected targets or pathways. The genomic changes identified by microarray generated 
eight possible affected cellular processes organized and elucidated by GoMiner. These
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processes included signal transduction, phosphorus metabolism and cellular proliferation. 
With the preponderance o f experimental data showing OPs decrease or inhibit cellular 
proliferation at micromolar to millimolar concentrations (Rodriguez and Bustos-Obregon 
2000; Guizzetti et al. 2005), we hypothesized that a low concentration (nanomolar) dose 
of PX might actually stimulate proliferation.
After deciding to further investigate the effect o f PX exposure on cellular 
proliferation, a more careful analysis was performed on the up- and downregulated genes 
to identity any other genes identified in the microarray experiment that might be involved 
in cellular proliferation, but were not identified by GoMiner. Two other genes, in 
addition to the genes named by GoMiner, Ornithine decarboxylase 1 (ODCl) and 
Extracellular matrix protein 1 (ECM l) were classified as genes involved in cellular 
proliferation. These were also the two genes that chosen for the validation o f the 
microarray results (previous chapter). In addition, both ODCl and ECMl were very 
good hits from the microarray data, with a high number of valid spots, low STDEV, and a 
significant fold change.
ODCl is a key, rate-limiting enzyme in the biosynthesis of polyamines in 
mammalian cells (Shantz and Pegg 1999; Zhang and Chen 2002; Hu et al. 2003). The 
polyamines putrescine, spermidine, and spermine are essential for cellular growth, 
differentiation and proliferation (Mohan et al. 1999). Upregulation of ODCl gene, 
protein level, and enzyme activity has been implicated in the induction of cell 
proliferation, and ODCl has also been shown to be constitutively expressed at increased 
levels in cancer (immortal) cells (Mohan et al. 1999; Klekner et al. 2001 ; Hu et al. 2003).
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The choice o f ECMl as a gene to use to both confirm the microarray data and 
characterize its existence in SH-SY5Y cells, is due to its role in proliferation as well as 
ECMl being a relatively newly discovered protein. ECMl is a widely expressed 
glycoprotein that has been characterized in cell proliferation, angiogenesis, 
differentiation, as well as regulation o f basement membrane and growth factor binding 
within the skin (Wang et al. 2003; Chan 2004; Lupo et al. 2005). ECMl consists o f three 
known splice variants ECMl a, ECM lb, and ECMlc. ECMl a is widely expressed and is 
found in various tissues including skin, liver, lung, ovary, prostate, skeletal muscle and 
heart. ECM lb on the other hand has only been discovered in tonsils, kératinocytes, and 
tissue of the upper respiratory tract (Fujimoto et al. 2005). ECM lc has yet to be fully 
characterized with respect to its distribution and expression, but has been shown to 
account for approximately 15% of skin ECMl RNA (Chan 2004). Protein levels of 
ECMl have shown increased expression in malignant epithelial tumors (breast and lung) 
(Han et al. 2001; Wang et al. 2003) and have has been used as a diagnostic marker in 
malignant thyroid neoplasms (Kebebew et al. 2005).
Because a considerable number of genes (ten) involved in cellular proliferation 
showed an upregulation in response to 10 nM PX exposure, experiments were devised to 
test the hypothesis that PX causes an increase in proliferation. The data presented in this 
chapter documents the experimental work done to prove the idea that exposure to 10 nM 
PX induces cellular proliferation.
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Results
In order to assess the potential effect of 10 nM PX on cellular proliferation, 
growing SH-SY5Y cells were used. SH-SY5Y cells have been used previously as in 
vitro models to study and characterize neuronal growth (Matthews and Feldman 1996; 
Celli et al. 1999). Two different experimental approaches were taken to identify cellular 
proliferation; manual cell counting and MTT assay.
The manual cell counting method involved plating cells in 6  well plates and 48 h 
later treating with 10 nM PX or acetone control. After 6  days o f PX treatment, cells were 
removed from the plate and counted (Figure 7.1). Cells treated with 10 nM PX showed a 
significant (p<0.005) increase in cell number compared to cells treated with acetone 
vehicle. In general, about a 1.3 — 1.4 fold increase in cell number was observed 
throughout the replicate experiments. To rule out the possibility that PX was interacting 
with a component in the medium, which in turn secondarily caused cell proliferation, 
media was pre-treated with 10 nM PX and allowed to incubate at 37°C for 48 h before 
addition to the cells. Pre-treatment of media with PX resulted in no significant (p>0.05) 
proliferation relative to control (Figure 7.2).
To supplement and confirm the cell counting experiment, cellular proliferation in 
SH-SY5Y cells was also assessed by MTT assay. The MTT assay is a colorimetric assay 
that analyzes proliferation by measuring the cleavage product (purple formazan crystals) 
o f yellow tétrazolium salt MTT by the mitochondrial enzyme succinic dehydrogenase, 
which is active in proliferating cells. SH-SY5Y cells were treated with 10 nM, 1 nM, or 
acetone vehicle for 4 days and then analyzed for cellular proliferation using the MTT
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assay. Results are shown in Figure 7.3. The MTT assay showed an approximate increase 
in cellular proliferation of 1.2 fold following 10 nM PX exposure. Treatment of SH- 
SY5Y cells with 1 nM PX showed no increase in proliferation compared to control.
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Figure 7.1
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Figure 7.1. 10 uM PX induces cellular proliferation. SH-SY5Y cells were passed into 
a 6  well plate at 1x10® cells/well. Treatment started 48 h post plating. Cells were 
counted 6  days after treatment using a hemacytometer. Graph representative of three 
experiments, each done in triplicate. ** p<0.005, (impaired t test)
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Figure 7.2. Media pre-treated with 10 nM PX does not induce cellular proliferation.
SH-SY5Y cells were passed into a 6  well plate at 1x10^ cells/well. Media was treated 
with 10 nM PX 48 h and allowed to incubate at 37®C before addition to the cells. Cells 
were counted 6  days after treatment using a hemacytometer. Graph representative o f two 
experiments, each done in triplicate. P>0.05 (unpaired t test)
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Figure 7.3
1.2
1.0-  
0.8-
o  0.6- 
O
0.4-
0.2-
0.0
C ontrol 1 nM PX 10 nM PX 
T re a tm e n t
Figure 7.3. M easurement of SH-SY5Y cellular proliferation by M TT assay. SH- 
SY5Y cells were passed into a 96 well plate at 1 and 3x1 O'* cells/well. Treatment started 
48 h post plating. Cells were measured for proliferation 4 days after treatment using an 
MTT assay. Graph representative of six experiments (three at 1x10* and three at 3x10* 
cells/well), each done in triplicate. Similar changes were observed for 1 and 3x10* 
cells/well. * p<0.05, (unpaired t test)
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Discussion
Results from the cell counting experiment and MTT assay corroborate our 
hypothesis that low dose (10 nM) PX induces cellular proliferation. Two approaches 
were used to evaluate cellular proliferation induced by PX. In the first, human 
neuroblastoma SH-SY5Y cells showed increased proliferation of about 1.3-1.4 fold 
following a 6  day treatment o f 10 nM PX. The cells also showed a significant (p<0.05) 
increase o f 1.2 fold by MTT assay after 4 days of 10 nM PX exposure. However, the 
increase in proliferation was reduced when the concentration o f PX was ten fold less (1 
nM). The MTT assay (4 day PX treatment) might have shown a similar fold change to 
the cell counting experiment ( 6  day PX treatment) if the PX exposure was carried out an 
additional two days. However, the small quantity of media in the 96 well plate did not 
allow for this.
The MTT assay measures the activity o f a mitochondrial enzyme, so it is 
appropriate to ask whether OPs directly target mitochondria. Research has shown that 
exceedingly high levels (100 fiM -  1 mM) of OPs hyperpolarize the mitochondrial 
transmembrane potential in SH-SY5Y cells (Carlson and Ehrich 1999). However, the 
change in potential was not directly correlated to OPs and is possibly the secondary result 
of OP cytotoxicity (apoptosis).
A number of other cell counting experiments were performed to further 
characterize cellular proliferation. Media was pre-treated with 10 nM PX and allowed to 
incubate at 37®C for 48 h prior to addition to the cells, which resulted in no increase in 
cellular proliferation. This experiment ruled out the possibility that PX was reacting with
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components in the media which secondarily caused cellular proliferation. Multiple doses 
of PX throughout the 6  day treatment period were also experimentally examined. The 
results of this experiment again showed no increase in cellular proliferation compared to 
control. This might be due to the fact that each successive dose resulted in increased 
concentrations o f PX, therefore blocking the proliferation phenotype.
There are different methods to measure cellular proliferation in addition to cell 
counting by hemacytometer and MTT assay. Using the same experimental setup as the 
cell counting by hemacytometer, SH-SY5Y cells were also counted using a Coulter 
Counter. Results from the Coulter Counter were quite varied. In one experiment there 
would be induction of proliferation followed by an experiment that showed no induction 
or even a decrease in cellular proliferation. The tendency o f SH-SY5Y cells to aggregate 
and form clumps resulted in inconsistent counts with the Coulter Counter. A research 
group measuring cellular proliferation in SH-SY5Y cells noted that the MTT assay is the 
superior choice for measuring proliferation in this specific cell line (Celli et al. 1999).
A comprehensive literature search uncovered a single paper that investigated low 
level OP exposure and cell proliferation. The OP methamidophos stimulated cell 
proliferation of SH-SY5Y by 28% at a concentration of 700 nM, and inhibited 
proliferation by 62% after exposure to 7 mM as determined by MTT assay (Li et al.
2003). Calcium uptake was also measured following exposure to methamidophos. SH- 
SY5Y cells showed decrease uptake and markedly increased uptake of calcium at high 
and low levels of methamidophos, respectively. Their conclusion was that 
methamidophos was disrupting calcium homeostasis which was leading to the increase or 
inhibition of proliferation depending on the concentration o f OP. While the work
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discussed in this chapter shows a similar end result, the data presented here provides 
evidence that 10 nM PX is upregulating a number o f cellular proliferation genes resulting 
in the induction o f proliferation.
Interestingly, a number o f studies have linked occupational exposure o f OP 
pesticides with an increased risk o f non-Hodgkin’s lymphoma (McDuffie 1994; Fritschi 
et al. 2005). Another study demonstrated that malathion and parathion (0.167xLDso and 
0.5x LD5 0 , respectively, 2 times daily for 5 days) induced proliferation of terminal end 
buds of mammary glands followed by formation of mammary carcinomas in Sprague- 
Dawley female rats (Cabello et al. 2001). OPs, as a general class, have not been 
characterized as carcinogens, but these studies and the fact that 10 nM PX induces 
cellular proliferation support the hypothesis that OPs may be implicated in cancer. 
However, caution should be taken in interpreting the in vitro data from this chapter in that 
it does not take into account the toxicokinetic factors of an in vivo model.
The cell cycle is a highly regulated process that is tightly associated with cellular 
proliferation. There a large variety o f signals, including growth factors, cytokines, and 
mitogens, that induce cells to divide (Alberts 2002). The signals that induce proliferation 
are moved through a number of different signaling pathways that include the MAP 
kinase. Protein kinase C, and JAK/STAT pathways (Alberts 2002). Further work would 
need to be done to identify if  the upregulation of cellular proliferation genes, and the 
increased levels of ECMl protein, are due to direct action of PX acting as a growth 
factor, or are a secondary result o f a target or signaling pathway being modulated by PX, 
which in turn leads to an upregulation of proliferation genes. Also, because this work 
was done in an immortal cell line, which already have a number of proliferation genes
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constitutively expressed, additional experiments would need to be done on primary cell 
lines to see if  low dose PX induces the same phenotype.
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Chapter 8
CONCLUSIONS AND FUTURE WORK
The initial discovery and development o f OPs led to the characterization of the 
main mechanism of OP toxicity, the inhibition o f AChE. Further work defined the 
consequences of this inhibition, namely cholinergic crisis. Recent research into OPs 
toxicity has identified other significant secondary targets and outcomes o f OP exposure 
that include OPIDN and OPICN. While the clinical manifestations o f OP exposure, 
outside of AChE inhibition, have been fairly well characterized, the cellular components, 
mechanisms and pathways that are involved in the disease’s progressions are obscure.
The work presented in this thesis begins to characterize the possible pathways and targets 
altered by OP exposure. Using cDNA microarray, transcriptional changes in the SH- 
SY5Y human neuroblastoma cell line were measured after treatment with 10 nM 
paraoxon (PX). The results of this experiment led to the following conclusion:
• Acute, low-level exposure to PX induced the up- and downregulation of a 
number of genes. Using GoMiner software, it was determined that a number of different 
cellular processes were modulated following PX exposure. Analysis of the GoMiner data 
resulted in eight biological processes showing induction o f genes associated with those 
processes. These processes include, cell communication, phosphorus metabolism, 
cellular proliferation, cellular lipid metabolism, cellular transport, cell differentiation, cell 
cycle, and cytoskeleton organization and biogenesis.
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Because OPs have been implicated with the development o f cancer and the fact 
that a number of genes from the microarray data were grouped under cellular 
proliferation, experiments were devised to test the hypothesis that exposure to 10 nM PX 
induces cellular proliferation. The findings of these experiments are summarized below:
•  10 nM  PX exposure induced significant cellular proliferation in SH-SY5Y 
hum an neuroblastoma cells. Using two different techniques to measure cellular 
proliferation, it was shown that exposure to 10 nM PX induces a small, but significant 
proliferation. The MTT assay showed about a 1.2 fold increase in proliferation at 10 nM 
PX while 1 nM PX showed no increase. The cell counting experiment measured an 
approximately 1.3 fold induction o f cellular proliferation. Further work needs to be done 
to fully characterize changes in proliferation at different time points and different 
concentrations of PX.
The microarray data in chapter 5 was attempted to be confirmed using a number 
of different techniques including semi-quantitative RT-PCR, immunoblot, and enzyme 
activity assay. A unique finding from these confirmation experiments is detailed below:
• Expression of E C M l in SH-SY5Y hum an neuroblastomas was confirmed by RT- 
PCR and immunoblot. ECMl is a recently discovered protein that has yet to be fully 
characterized with respect to its expression. ECMl expression has been identified in a 
number of tissues including skin, blood vessels, heart, placenta, tonsils, liver and lung.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
89
By northern blot, ECMl expression was not detected in brain, but neuroblastomas have 
not been tested for ECMl expression. The characterization of ECMl by RT-PCR and 
immunoblot in SH-SY5Y confirms the presence of the gene and protein. Exposure to 10 
nM PX induces the increased expression o f protein levels as shown by microarray and 
immunoblot.
Overall, the work detailed in this study contributes to an initial understanding of 
gene changes in response to PX exposure. The microarray data presented here resulted 
from the use of a Human Tox cDNA chip. The use of a full genome oligo microarray 
chip would allow the researcher the opportunity to more fully characterize genomic 
changes after PX exposure. Additional experiments with different concentrations of PX, 
or different types of OPs, and different time points would also be advantageous in 
creating toxic footprints of all types of OPs. Examination of data from different OPs and 
concentrations might also identify possible biomarkers of OP exposure. OPs as a class 
might upregulate certain genes they all have in common, but also a characteristically 
unique set of genes by which to identify specific OPs. The identification of biomarkers 
would be useful in developing screening techniques for OP exposure in humans. 
Following the additional microarray work, experiments devised to test specific pathways 
and protein targets could lead to a better understanding of OPs toxicity and clinical 
outcomes. Clearly, further work is needed in characterizing the protein targets and 
cellular pathways affected by OPs.
The identification o f specific cellular machinery involved with proliferation 
following OP exposure is also important. From the work presented here, it is not possible
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to determine whether PX is the primary cause of proliferation or if  proliferation is a 
secondary result o f some other PX interaction within the cell. The examination of the 
ability o f different OPs to cause proliferation, and the exploration into whether or not 
OPs cause proliferation in other cell lines and specific tissues would also need to be 
performed.
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